{
  "conditions_to_closing": [
    {
      "section": "conditions_to_closing",
      "field_name": "mutual_conditions_list",
      "answer": [
        "The Company Shareholder Approval shall have been obtained.",
        "The shares of Parent Common Stock to be issued in the Merger shall have been approved for listing on Nasdaq, subject to official notice of issuance.",
        "The Form S-4 shall have been declared effective by the SEC under the Securities Act and no stop order suspending the effectiveness of the Form S-4 shall have been issued by the SEC and no proceedings for that purpose shall have been initiated by the SEC.",
        "The consummation of the Merger shall not be restrained, enjoined or prohibited by any Order of a court of competent jurisdiction or any other Governmental Entity that is continuing and remains in effect and no applicable Law shall be effective that prohibits the consummation of the Merger.",
        "Any applicable waiting period, together with any extensions thereof, under the HSR Act shall have expired or been terminated.",
        "All waivers, consents, clearances, approvals and authorizations under the Regulatory Laws set forth on Section 6.1(d) of the Company Disclosure Schedule with respect to the Transactions shall have been obtained and shall remain in full force and effect."
      ],
      "summary": "The mutual conditions for closing include obtaining Company Shareholder Approval, Nasdaq listing approval, SEC effectiveness of Form S-4, absence of legal prohibitions, expiration of HSR Act waiting periods, and obtaining necessary regulatory approvals.",
      "confidence": 0.95,
      "reason": "The conditions are explicitly listed under Section 6.1 as requirements for both parties to consummate the merger.",
      "clause_text": "The respective obligations of each party to consummate the Merger shall be subject to the satisfaction (or waiver, if permissible under Law) at or prior to the Effective Time of each of the following conditions: (a) The Company Shareholder Approval shall have been obtained. (b) The shares of Parent Common Stock to be issued in the Merger shall have been approved for listing on Nasdaq, subject to official notice of issuance. The Form S-4 shall have been declared effective by the SEC under the Securities Act and no stop order suspending the effectiveness of the Form S-4 shall have been issued by the SEC and no proceedings for that purpose shall have been initiated by the SEC. (c) The consummation of the Merger shall not be restrained, enjoined or prohibited by any Order (whether temporary, preliminary or permanent) of a court of competent jurisdiction or any other Governmental Entity that is continuing and remains in effect (other than any such Order issued pursuant to or to enforce a Regulatory Law, which Order is not material to Parent and its Subsidiaries (assuming consummation of the Transactions), taken as a whole) and no applicable Law shall be effective that prohibits the consummation of the Merger (other than any Regulatory Law that is not material to Parent and its Subsidiaries (assuming consummation of the Transactions), taken as a whole). (d) Any applicable waiting period, together with any extensions thereof, under the HSR Act shall have expired or been terminated. All waivers, consents, clearances, approvals and authorizations under the Regulatory Laws set forth on Section 6.1(d) of the Company Disclosure Schedule with respect to the Transactions shall have been obtained and shall remain in full force and effect.",
      "reference_section": "ARTICLE Article 6 Conditions to Consummation of the Merger > Section 6.1 Conditions to Obligations of Each Party Under This Agreement"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "parent_closing_conditions",
      "answer": [
        "Each representation and warranty of the Company specified in certain sections must be true and correct in all material respects at the Closing Date.",
        "The Company must have performed and complied in all material respects with all covenants and agreements required under the Agreement at or prior to the Closing Date.",
        "No Company Material Adverse Effect shall have occurred since the date of the Agreement and be continuing.",
        "The Company must deliver to Parent a certificate, dated the Closing Date and signed by an executive officer, certifying that the conditions set forth in Sections 6.3(a), 6.3(b), and 6.3(c) have been satisfied."
      ],
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "company_closing_conditions",
      "answer": [
        "Each representation and warranty of Parent and Merger Sub contained in this Agreement shall be true and correct at and as of the Closing Date.",
        "Parent and Merger Sub shall have performed or complied in all material respects with all covenants and agreements required to be performed or complied with by them under this Agreement at or prior to the Closing Date.",
        "Parent shall have delivered to the Company a certificate, dated the Closing Date and signed by an executive officer of Parent, certifying to the effect that the conditions set forth in Sections 6.2(a) and 6.2(b) have been satisfied."
      ],
      "summary": "The Company must ensure that Parent and Merger Sub's representations and warranties are accurate, they have complied with all covenants, and a certificate confirming these conditions is delivered.",
      "confidence": 0.95,
      "reason": "The conditions for the Company's obligation to close the transaction are explicitly outlined in Section 6.2.",
      "clause_text": "The obligation of the Company to effect the Merger is further subject to the fulfillment (or waiver by the Company) at or prior to the Effective Time of the following conditions: (a) Each representation and warranty of Parent and Merger sub contained in this Agreement, without giving effect to any qualifications as to materiality or 'Parent Material Adverse Effect' or other similar qualifications contained therein, shall be true and correct at and as of the Closing Date as if made on the Closing Date, except for representations and warranties that relate to a specific date or time (which need only be true and correct as of such date or time), and except as has not had and would not reasonably be expected to have, individually or in the aggregate with all other failures to be true or correct, a Parent Material Adverse Effect. (b) Parent and Merger Sub shall have performed or complied in all material respects with all covenants and agreements required to be performed or complied with by them under this Agreement at or prior to the Closing Date. (c) Parent shall have delivered to the Company a certificate, dated the Closing Date and signed by an executive officer of Parent, certifying to the effect that the conditions set forth in Sections 6.2(a) and 6.2(b) have been satisfied.",
      "reference_section": "ARTICLE Article 6 Conditions to Consummation of the Merger > Section 6.2 Conditions to Obligations of the Company Under This Agreement"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "target_shareholder_approval_required",
      "answer": true,
      "summary": "The agreement requires the affirmative vote of the shareholders of the Company representing not less than two-thirds of the votes cast at the Company Meeting for approval of the Agreement, the Merger, and the consummation of the Transactions.",
      "confidence": 1.0,
      "reason": "The requirement for Company Shareholder Approval is explicitly stated as a condition to consummate the Merger.",
      "clause_text": "The respective obligations of each party to consummate the Merger shall be subject to the satisfaction (or waiver, if permissible under Law) at or prior to the Effective Time of each of the following conditions: (a) The Company Shareholder Approval shall have been obtained.",
      "reference_section": "ARTICLE Article 6 Conditions to Consummation of the Merger > Section 6.1 Conditions to Obligations of Each Party Under This Agreement > (a)"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "target_shareholder_approval_threshold",
      "answer": "two-thirds (2/3) of the votes cast",
      "summary": "The threshold for Target shareholder approval to close the transaction is the affirmative vote of shareholders representing not less than two-thirds (2/3) of the votes cast at the Company Meeting.",
      "confidence": 1.0,
      "reason": "The document explicitly states the required threshold for shareholder approval as two-thirds (2/3) of the votes cast.",
      "clause_text": "Company Shareholder Approval means the affirmative vote of the shareholders of the Company representing not less than two-thirds (2/3) of the votes cast at the Company Meeting with respect to the approval of this Agreement, the Merger and the consummation of the Transactions.",
      "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Shareholder Approval"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "hsr_clearance_required",
      "answer": true,
      "summary": "The agreement explicitly requires that any applicable waiting period under the HSR Act shall have expired or been terminated as a condition to consummate the merger.",
      "confidence": 1.0,
      "reason": "The requirement for HSR Act clearance is explicitly stated as a condition to the obligations of each party to consummate the merger.",
      "clause_text": "Any applicable waiting period, together with any extensions thereof, under the HSR Act shall have expired or been terminated.",
      "reference_section": "ARTICLE Article 6 Conditions to Consummation of the Merger > Section 6.1 Conditions to Obligations of Each Party Under This Agreement > (d)"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "other_customary_conditions",
      "answer": [
        "The Company Shareholder Approval shall have been obtained.",
        "The shares of Parent Common Stock to be issued in the Merger shall have been approved for listing on Nasdaq, subject to official notice of issuance.",
        "The Form S-4 shall have been declared effective by the SEC under the Securities Act and no stop order suspending the effectiveness of the Form S-4 shall have been issued by the SEC and no proceedings for that purpose shall have been initiated by the SEC.",
        "The consummation of the Merger shall not be restrained, enjoined or prohibited by any Order of a court of competent jurisdiction or any other Governmental Entity that is continuing and remains in effect.",
        "No applicable Law shall be effective that prohibits the consummation of the Merger.",
        "Any applicable waiting period, together with any extensions thereof, under the HSR Act shall have expired or been terminated.",
        "All waivers, consents, clearances, approvals and authorizations under the Regulatory Laws set forth on Section 6.1(d) of the Company Disclosure Schedule with respect to the Transactions shall have been obtained and shall remain in full force and effect."
      ],
      "summary": "The agreement outlines several customary conditions to closing, including shareholder approval, listing approval, SEC effectiveness of Form S-4, absence of legal prohibitions, expiration of HSR Act waiting periods, and obtaining necessary regulatory approvals.",
      "confidence": 0.95,
      "reason": "The conditions listed are standard requirements for closing a merger, as they involve regulatory approvals, legal clearances, and shareholder consent.",
      "clause_text": "The respective obligations of each party to consummate the Merger shall be subject to the satisfaction (or waiver, if permissible under Law) at or prior to the Effective Time of each of the following conditions: (a) The Company Shareholder Approval shall have been obtained. (b) The shares of Parent Common Stock to be issued in the Merger shall have been approved for listing on Nasdaq, subject to official notice of issuance. The Form S-4 shall have been declared effective by the SEC under the Securities Act and no stop order suspending the effectiveness of the Form S-4 shall have been issued by the SEC and no proceedings for that purpose shall have been initiated by the SEC. (c) The consummation of the Merger shall not be restrained, enjoined or prohibited by any Order (whether temporary, preliminary or permanent) of a court of competent jurisdiction or any other Governmental Entity that is continuing and remains in effect (other than any such Order issued pursuant to or to enforce a Regulatory Law, which Order is not material to Parent and its Subsidiaries (assuming consummation of the Transactions), taken as a whole) and no applicable Law shall be effective that prohibits the consummation of the Merger (other than any Regulatory Law that is not material to Parent and its Subsidiaries (assuming consummation of the Transactions), taken as a whole). (d) Any applicable waiting period, together with any extensions thereof, under the HSR Act shall have expired or been terminated. All waivers, consents, clearances, approvals and authorizations under the Regulatory Laws set forth on Section 6.1(d) of the Company Disclosure Schedule with respect to the Transactions shall have been obtained and shall remain in full force and effect.",
      "reference_section": "ARTICLE Article 6 Conditions to Consummation of the Merger > Section 6.1 Conditions to Obligations of Each Party Under This Agreement"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "financial_conditions_minimum_cash_threshold",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "financial_conditions_maximum_net_debt",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "financial_conditions_minimum_any_condition",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "tax_conditions_tax_opinion_required",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    }
  ],
  "material_adverse_effect": {
    "mae_carveout": [
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_general_economic_conditions_included",
        "answer": true,
        "summary": "The MAE definition excludes adverse effects resulting from actions taken by the Company at the direction, request, or with the consent of the Parent.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that any action taken or refrained from being taken, to which the Parent has expressly approved, consented to, or requested in writing, shall not constitute a Company Material Adverse Effect.",
        "clause_text": "any action taken or refrained from being taken, in each case to which Parent has expressly approved, consented to or requested in writing (including by email) that such action be taken or refrained from being taken following the date of this Agreement.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_general_economic_conditions_explanation",
        "answer": "Adverse effects resulting from general economic conditions are excluded from the definition of Material Adverse Effect.",
        "summary": "Adverse effects resulting from general economic conditions, such as changes in markets, economic downturns, interest rates, inflation, or geopolitical events, are excluded from the definition of Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that adverse effects arising from changes in general economic, business, labor, or regulatory conditions, or changes in financial markets, including interest rates or exchange rates, shall not be taken into account in determining a Material Adverse Effect.",
        "clause_text": "provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, except that Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries: (a) changes or proposed changes in applicable Laws, GAAP or the interpretation or enforcement thereof, (b) changes in general economic, business, labor or regulatory conditions, or changes in securities, credit or other financial markets, including interests rates or exchange rates, in Taiwan, the United States or globally, or changes generally affecting companies in the industry or industries (including seasonal fluctuations) in which the Company or its Subsidiaries operate in Taiwan, the United States or globally, (c) changes in global or national political conditions (including the outbreak or escalation of war (whether or not declared), military action or operation, sabotage, civil unrest, civil disobedience, national or international calamity, the outbreak of hostilities or acts of terrorism), changes due to natural disasters or changes in the weather or changes due to the outbreak or worsening of an epidemic, pandemic or other health crisis (including COVID-19, or any COVID-19 Measures or Permitted Actions or changes in such COVID-19 Measures or Permitted Actions after the date of this Agreement)",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_industry_conditions_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes changes generally affecting companies in the industry or industries in which the Company operates from constituting a Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that adverse effects arising from changes generally affecting companies in the industry or industries in which the Company operates shall not constitute a Company Material Adverse Effect.",
        "clause_text": "provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, except that Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries: ... (b) changes in general economic, business, labor or regulatory conditions, or changes in securities, credit or other financial markets, including interests rates or exchange rates, in Taiwan, the United States or globally, or changes generally affecting companies in the industry or industries (including seasonal fluctuations) in which the Company or its Subsidiaries operate in Taiwan, the United States or globally,",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_industry_conditions_explanation",
        "answer": "changes generally affecting companies in the industry or industries (including seasonal fluctuations) in which the Company or its Subsidiaries operate in Taiwan, the United States or globally",
        "summary": "The clause excludes changes generally affecting companies in the industry or industries in which the Company operates from the definition of a Company Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that changes generally affecting companies in the industry or industries in which the Company operates are excluded from being considered a Company Material Adverse Effect.",
        "clause_text": "changes generally affecting companies in the industry or industries (including seasonal fluctuations) in which the Company or its Subsidiaries operate in Taiwan, the United States or globally",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_stock_price_changes_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes changes in the trading price or trading volume of Shares or ADS from constituting a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that changes in the trading price or trading volume of Shares or ADS shall not constitute a Company Material Adverse Effect.",
        "clause_text": "Company Material Adverse Effect means any change, event, occurrence or development (an \"Effect\") that, individually or in the aggregate, has had or would reasonably be expected to have, a material adverse effect on the business, financial condition, assets, liabilities or results of operations of the Company and its Subsidiaries, taken as a whole; provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur... (g) changes in the trading price or trading volume of Shares or ADS or any suspension of trading...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_stock_price_changes_explanation",
        "answer": "Changes in the trading price or trading volume of Shares or ADS or any suspension of trading, or any changes in the ratings or the ratings outlook for the Company by any applicable rating agency or changes in any analyst's recommendations or ratings with respect to the Company are excluded from the definition of a Company Material Adverse Effect.",
        "summary": "The clause excludes changes in the Company's stock price, market capitalization, or trading volume from constituting a Company Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that changes in trading price or volume are not considered a Company Material Adverse Effect.",
        "clause_text": "Changes in the trading price or trading volume of Shares or ADS or any suspension of trading, or any changes in the ratings or the ratings outlook for the Company by any applicable rating agency or changes in any analyst's recommendations or ratings with respect to the Company (provided, that for purposes of this clause (g) the underlying cause of such change may be taken into account in determining whether a Company Material Adverse Effect has occurred).",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_credit_rating_changes_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes changes in credit ratings, analyst outlooks, or recommendations from constituting a Material Adverse Effect.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that changes in the ratings or the ratings outlook for the Company by any applicable rating agency or changes in any analyst's recommendations or ratings with respect to the Company shall not constitute a Company Material Adverse Effect.",
        "clause_text": "Company Material Adverse Effect means any change, event, occurrence or development (an \"Effect\") that, individually or in the aggregate, has had or would reasonably be expected to have, a material adverse effect on the business, financial condition, assets, liabilities or results of operations of the Company and its Subsidiaries, taken as a whole; provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect... (g) changes in the trading price or trading volume of Shares or ADS or any suspension of trading, or any changes in the ratings or the ratings outlook for the Company by any applicable rating agency or changes in any analyst's recommendations or ratings with respect to the Company (provided, that for purposes of this clause (g) the underlying cause of such change may be taken into account in determining whether a Company Material Adverse Effect has occurred)...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_credit_rating_changes_explanation",
        "answer": "Changes in the ratings or the ratings outlook for the Company by any applicable rating agency or changes in any analyst's recommendations or ratings with respect to the Company are excluded from the definition of a Company Material Adverse Effect.",
        "summary": "Changes in credit ratings, analyst outlooks, or recommendations are excluded from the definition of a Company Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that changes in ratings or analyst recommendations do not constitute a Company Material Adverse Effect.",
        "clause_text": "any changes in the ratings or the ratings outlook for the Company by any applicable rating agency or changes in any analyst's recommendations or ratings with respect to the Company (provided, that for purposes of this clause (g) the underlying cause of such change may be taken into account in determining whether a Company Material Adverse Effect has occurred)",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_legal_or_regulatory_changes_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes changes in laws, regulations, GAAP, or accounting principles from constituting a Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that adverse effects arising from changes in applicable laws, GAAP, or their interpretation shall not constitute a Company Material Adverse Effect.",
        "clause_text": "provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, except that Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries: (a) changes or proposed changes in applicable Laws, GAAP or the interpretation or enforcement thereof,",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_legal_or_regulatory_changes_explanation",
        "answer": "changes or proposed changes in applicable Laws, GAAP or the interpretation or enforcement thereof",
        "summary": "The clause excludes changes or proposed changes in applicable laws, GAAP, or their interpretation or enforcement from being considered a Company Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that changes in laws, GAAP, or their interpretation are not to be considered as contributing to a Company Material Adverse Effect.",
        "clause_text": "provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, except that Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries: (a) changes or proposed changes in applicable Laws, GAAP or the interpretation or enforcement thereof",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_force_majeure_events_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes natural disasters and weather changes from constituting a Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that adverse effects resulting from natural disasters or weather changes shall not constitute a Material Adverse Effect.",
        "clause_text": "provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, ... changes due to natural disasters or changes in the weather ...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_force_majeure_events_explanation",
        "answer": "changes due to natural disasters or changes in the weather",
        "summary": "The definition of Material Adverse Effect excludes changes due to natural disasters or changes in the weather from being considered a Material Adverse Effect.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that changes due to natural disasters or changes in the weather shall not constitute a Material Adverse Effect.",
        "clause_text": "changes due to natural disasters or changes in the weather or changes due to the outbreak or worsening of an epidemic, pandemic or other health crisis",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_political_events_or_war_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes acts of war, terrorism, military conflict, or geopolitical instability from constituting a Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that adverse effects arising from changes in global or national political conditions, including war and terrorism, shall not constitute a Material Adverse Effect.",
        "clause_text": "provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, except that Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries: (c) changes in global or national political conditions (including the outbreak or escalation of war (whether or not declared), military action or operation, sabotage, civil unrest, civil disobedience, national or international calamity, the outbreak of hostilities or acts of terrorism)",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_political_events_or_war_explanation",
        "answer": "changes in global or national political conditions (including the outbreak or escalation of war (whether or not declared), military action or operation, sabotage, civil unrest, civil disobedience, national or international calamity, the outbreak of hostilities or acts of terrorism)",
        "summary": "The clause excludes changes in global or national political conditions, including acts of war, terrorism, and related events, from the definition of a Company Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly lists acts of war, terrorism, and political instability as exclusions from the Company Material Adverse Effect definition.",
        "clause_text": "changes in global or national political conditions (including the outbreak or escalation of war (whether or not declared), military action or operation, sabotage, civil unrest, civil disobedience, national or international calamity, the outbreak of hostilities or acts of terrorism)",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_pandemic_health_events_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes adverse effects due to pandemics, epidemics, or other health crises, including COVID-19.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that adverse effects due to the outbreak or worsening of an epidemic, pandemic, or other health crisis, including COVID-19, do not constitute a Material Adverse Effect.",
        "clause_text": "Company Material Adverse Effect means any change, event, occurrence or development (an \"Effect\") that, individually or in the aggregate, has had or would reasonably be expected to have, a material adverse effect on the business, financial condition, assets, liabilities or results of operations of the Company and its Subsidiaries, taken as a whole; provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, except that Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries: (a) changes or proposed changes in applicable Laws, GAAP or the interpretation or enforcement thereof, (b) changes in general economic, business, labor or regulatory conditions, or changes in securities, credit or other financial markets, including interests rates or exchange rates, in Taiwan, the United States or globally, or changes generally affecting companies in the industry or industries (including seasonal fluctuations) in which the Company or its Subsidiaries operate in Taiwan, the United States or globally, (c) changes in global or national political conditions (including the outbreak or escalation of war (whether or not declared), military action or operation, sabotage, civil unrest, civil disobedience, national or international calamity, the outbreak of hostilities or acts of terrorism), changes due to natural disasters or changes in the weather or changes due to the outbreak or worsening of an epidemic, pandemic or other health crisis (including COVID-19, or any COVID-19 Measures or Permitted Actions or changes in such COVID-19 Measures or Permitted Actions after the date of this Agreement)",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_pandemic_health_events_explanation",
        "answer": "Adverse Effects arising out of, resulting from or attributable to the outbreak or worsening of an epidemic, pandemic or other health crisis (including COVID-19) shall not constitute or be deemed to contribute to a Company Material Adverse Effect.",
        "summary": "Pandemics, epidemics, or public health emergencies, including COVID-19, are excluded from the definition of a Company Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that adverse effects from pandemics, including COVID-19, shall not be considered a Company Material Adverse Effect.",
        "clause_text": "Adverse Effects arising out of, resulting from or attributable to the outbreak or worsening of an epidemic, pandemic or other health crisis (including COVID-19, or any COVID-19 Measures or Permitted Actions or changes in such COVID-19 Measures or Permitted Actions after the date of this Agreement) shall not constitute or be deemed to contribute to a Company Material Adverse Effect.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_agreement_compliance_effects_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes effects resulting from the negotiation, announcement, pendency, or consummation of the merger agreement from constituting a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that adverse effects arising from the negotiation, announcement, pendency, or consummation of the agreement and the merger shall not constitute a Material Adverse Effect.",
        "clause_text": "provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, except that Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries: ... (e) the negotiation, announcement, pendency or consummation of this Agreement and the Merger, including the identity of, or the effect of any fact or circumstance relating to, Parent or any of its affiliates (provided that this clause (e) shall not apply to any representation or warranty to the extent the purpose of such representation or warranty is to address the consequences resulting from the negotiation, announcement, pendency, or consummation of this Agreement and the Merger), ...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_agreement_compliance_effects_explanation",
        "answer": "The negotiation, announcement, pendency or consummation of this Agreement and the Merger, including the identity of, or the effect of any fact or circumstance relating to, Parent or any of its affiliates, shall not constitute or be deemed to contribute to a Company Material Adverse Effect.",
        "summary": "Effects resulting from the negotiation, announcement, or consummation of the merger agreement are excluded from the definition of a Company Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly excludes effects from the negotiation, announcement, or consummation of the merger from being considered a Company Material Adverse Effect.",
        "clause_text": "the negotiation, announcement, pendency or consummation of this Agreement and the Merger, including the identity of, or the effect of any fact or circumstance relating to, Parent or any of its affiliates (provided that this clause (e) shall not apply to any representation or warranty to the extent the purpose of such representation or warranty is to address the consequences resulting from the negotiation, announcement, pendency, or consummation of this Agreement and the Merger)",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_parent_actions_included",
        "answer": true,
        "summary": "The MAE definition excludes adverse effects caused by actions or omissions of the Parent or its Affiliates if such actions are expressly approved, consented to, or requested in writing by the Company.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that any action taken or refrained from being taken, to which the Company has expressly approved, consented to, or requested in writing, shall not constitute a Parent Material Adverse Effect.",
        "clause_text": "any action taken or refrained from being taken, in each case to which the Company has expressly approved, consented to or requested in writing (including by email) that such action be taken or refrained from being taken following the date of this Agreement.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Parent Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_parent_actions_explanation",
        "answer": "Adverse effects resulting from actions taken by the Company at the direction, request, or with the consent of the Parent or its Affiliates are excluded from the definition of Material Adverse Effect.",
        "summary": "The definition of Company Material Adverse Effect excludes adverse effects from actions taken or refrained from being taken at the request or with the consent of the Parent.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that actions taken or refrained from being taken with Parent's consent are excluded from being considered a Material Adverse Effect.",
        "clause_text": "any action taken or refrained from being taken, in each case to which Parent has expressly approved, consented to or requested in writing (including by email) that such action be taken or refrained from being taken following the date of this Agreement",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_projections_miss_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes failures to meet projections, forecasts, estimates, or internal budgets from constituting a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that any failure by the Company or its Subsidiaries to meet any revenue, earnings or other financial projections or forecasts shall not constitute a Company Material Adverse Effect.",
        "clause_text": "any failure by the Company or any of its Subsidiaries to meet any revenue, earnings or other financial projections or forecasts (provided, that for purposes of this clause (h) the underlying cause of such failure may be taken into account in determining whether a Company Material Adverse Effect has occurred).",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_projections_miss_explanation",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_other_custom_items_present",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_other_custom_items",
        "answer": [
          {
            "label": "Approved Actions by Parent",
            "excerpt": "any action taken or refrained from being taken, in each case to which Parent has expressly approved, consented to or requested in writing (including by email) that such action be taken or refrained from being taken following the date of this Agreement"
          },
          {
            "label": "Proceedings from Fiduciary Duty Allegations",
            "excerpt": "any Proceeding arising from allegations of breach of fiduciary duty or violation of Law relating to the negotiation of this Agreement or any Competing Proposal or the approval of this Agreement or the Transactions by the Company Board"
          }
        ],
        "summary": "The MAE clause includes carve-outs for actions approved by the Parent and proceedings arising from fiduciary duty allegations.",
        "confidence": 0.9,
        "reason": "The clause explicitly lists these carve-outs, which are not part of the standard exclusions.",
        "clause_text": "provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, except that Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries: (d) any action taken or refrained from being taken, in each case to which Parent has expressly approved, consented to or requested in writing (including by email) that such action be taken or refrained from being taken following the date of this Agreement, (f) any Proceeding arising from allegations of breach of fiduciary duty or violation of Law relating to the negotiation of this Agreement or any Competing Proposal or the approval of this Agreement or the Transactions by the Company Board",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      }
    ],
    "mae_carveback": [
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_disproportionate_effects_included",
        "answer": true,
        "summary": "The MAE clause specifies that carve-outs are reintroduced if the Company is disproportionately affected compared to others in its industry.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that certain effects will be considered if they disproportionately impact the Company relative to other companies in the same industry.",
        "clause_text": "Company Material Adverse Effect means any change, event, occurrence or development (an \"Effect\") that, individually or in the aggregate, has had or would reasonably be expected to have, a material adverse effect on the business, financial condition, assets, liabilities or results of operations of the Company and its Subsidiaries, taken as a whole; provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, except that Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries:",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_disproportionate_effects_explanation",
        "answer": "Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries.",
        "summary": "The MAE definition includes a carve-back for disproportionate impacts on the Company relative to its industry peers.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that certain effects will be considered if they disproportionately impact the Company compared to others in the industry.",
        "clause_text": "Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_additional_exceptions_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_additional_exceptions_explanation",
        "answer": [
          "Effects with respect to clauses (a), (b) and (c) shall be considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries.",
          "For purposes of clause (g), the underlying cause of such change may be taken into account in determining whether a Company Material Adverse Effect has occurred.",
          "For purposes of clause (h), the underlying cause of such failure may be taken into account in determining whether a Company Material Adverse Effect has occurred."
        ],
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_causation_based_analysis_included",
        "answer": true,
        "summary": "The MAE definition includes language indicating that the underlying causes of certain excluded events, such as changes in stock price or failure to meet projections, may be considered in determining a Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The document explicitly states that the underlying cause of changes in trading price or failure to meet projections may be taken into account in determining a Material Adverse Effect.",
        "clause_text": "provided, that for purposes of this clause (g) the underlying cause of such change may be taken into account in determining whether a Company Material Adverse Effect has occurred) or (h) any failure by the Company or any of its Subsidiaries to meet any revenue, earnings or other financial projections or forecasts (provided, that for purposes of this clause (h) the underlying cause of such failure may be taken into account in determining whether a Company Material Adverse Effect has occurred).",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_causation_based_analysis_explanation",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "non_solicitation": {
    "no_shop_clause": [
      {
        "section": "non_solicitation",
        "field_name": "no_shop_clause_included",
        "answer": true,
        "summary": "The agreement includes a 'No-Shop' clause that restricts the Company from soliciting or engaging in discussions regarding Competing Proposals.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that the Company will not solicit or initiate discussions with third parties regarding Competing Proposals.",
        "clause_text": "(a) From and after the date of this Agreement until the earlier of the Effective Time or the date, if any, on which this Agreement is terminated in accordance with Article 7, and except as otherwise permitted in this Agreement, the Company will not, and it will cause the Subsidiaries of the Company and its and their respective directors and officers, and the Company shall instruct its and its Subsidiaries' financial advisors, investment bankers, legal counsel and other Representatives on behalf of the Company not to: (i) solicit or initiate or knowingly assist, facilitate or encourage any inquiry, proposal or offer that constitutes or would be reasonably expected to lead to a Competing Proposal or engage in any discussions or negotiations with respect thereto...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (a)"
      },
      {
        "section": "non_solicitation",
        "field_name": "no_shop_claus_explanation",
        "answer": "The Company is restricted from soliciting, initiating, or encouraging any competing acquisition proposals and from engaging in discussions or negotiations with third parties regarding such proposals, except under specific conditions outlined in the agreement.",
        "summary": "The Company is prohibited from soliciting or engaging in discussions for competing proposals, with limited exceptions.",
        "confidence": 0.9,
        "reason": "The clause explicitly prohibits the Company from engaging in activities related to competing proposals, with specific exceptions.",
        "clause_text": "From and after the date of this Agreement until the earlier of the Effective Time or the date, if any, on which this Agreement is terminated in accordance with Article 7, and except as otherwise permitted in this Agreement, the Company will not, and it will cause the Subsidiaries of the Company and its and their respective directors and officers, and the Company shall instruct its and its Subsidiaries' financial advisors, investment bankers, legal counsel and other Representatives on behalf of the Company not to: (i) solicit or initiate or knowingly assist, facilitate or encourage any inquiry, proposal or offer that constitutes or would be reasonably expected to lead to a Competing Proposal or engage in any discussions or negotiations with respect thereto...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (a)"
      }
    ],
    "notice_of_competing_offer": [
      {
        "section": "non_solicitation",
        "field_name": "notice_of_competing_offer_included",
        "answer": true,
        "summary": "The agreement requires the Company to promptly notify Parent within forty-eight (48) hours if it receives any Competing Proposal or inquiry that could lead to a Competing Proposal.",
        "confidence": 1.0,
        "reason": "The clause explicitly states the obligation for the Company to notify Parent of any Competing Proposal or related inquiry.",
        "clause_text": "From and after the date hereof until the earlier of the Effective Time or the date, if any, on which this Agreement is terminated in accordance with Article 7, the Company shall promptly (and in any event within forty-eight (48) hours) notify Parent in the event that the Company receives any Competing Proposal or any inquiry or request for information that could reasonably be expected to lead to a Competing Proposal.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (d)"
      },
      {
        "section": "non_solicitation",
        "field_name": "notice_of_competing_offer_explanation",
        "answer": "The Company is required to notify Parent promptly (and in any event within forty-eight (48) hours) of the identity of the Third Party making such Competing Proposal or inquiry or request and provide to Parent a copy of such Competing Proposal or inquiry or request (or, where no such copy is available, a reasonable description of the material terms and details thereof).",
        "summary": "The Company must notify Parent within 48 hours of receiving a Competing Proposal, including the Third Party's identity and material terms.",
        "confidence": 0.95,
        "reason": "The clause explicitly requires the Company to notify Parent of any Competing Proposal, including the identity and material terms.",
        "clause_text": "The Company shall notify Parent promptly (and in any event within forty-eight (48) hours) of the identity of the Third Party making such Competing Proposal or inquiry or request and provide to Parent a copy of such Competing Proposal or inquiry or request (or, where no such copy is available, a reasonable description of the material terms and details thereof).",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (d)"
      }
    ],
    "ongoing_update": [
      {
        "section": "non_solicitation",
        "field_name": "ongoing_update_included",
        "answer": true,
        "summary": "The agreement requires the Company to promptly notify Parent of any Competing Proposal or inquiry that could lead to a Competing Proposal, including the identity of the Third Party and material terms.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the Company shall notify Parent promptly of any Competing Proposal or inquiry, indicating an ongoing update requirement.",
        "clause_text": "From and after the date hereof until the earlier of the Effective Time or the date, if any, on which this Agreement is terminated in accordance with Article 7, the Company shall promptly (and in any event within forty-eight (48) hours) notify Parent in the event that the Company receives any Competing Proposal or any inquiry or request for information that could reasonably be expected to lead to a Competing Proposal.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (d)"
      },
      {
        "section": "non_solicitation",
        "field_name": "ongoing_update_explanation",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "superior_proposal_engagement": [
      {
        "section": "non_solicitation",
        "field_name": "superior_proposal_engagement_included",
        "answer": true,
        "summary": "The agreement permits the Company to engage in discussions or negotiations with a third party that submits a Superior Proposal under certain conditions, including fiduciary duties and written notice to the Parent.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that the Company may furnish information and engage in discussions or negotiations with a third party making a Competing Proposal that could lead to a Superior Proposal, subject to fiduciary duties and other conditions.",
        "clause_text": "(c) Notwithstanding anything to the contrary contained in Section 5.5(a), if at any time following the date hereof and prior to the receipt of the Company Shareholder Approval...then the Company and its Representatives may, directly or indirectly through the Company's Representatives: (A) furnish information with respect to the Company and its Subsidiaries...and (B) participate or engage in discussions or negotiations with the Third Party making such Competing Proposal...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (c)"
      },
      {
        "section": "non_solicitation",
        "field_name": "superior_proposal_engagement_explanation",
        "answer": "The Company and its Representatives may engage with third parties if a Superior Proposal is received, provided that the Company Board determines in good faith that not doing so would be inconsistent with their fiduciary duties.",
        "summary": "The Company is authorized to engage with third parties if a Superior Proposal is received, contingent upon the Company Board's good faith determination regarding fiduciary duties.",
        "confidence": 0.9,
        "reason": "The clause explicitly allows engagement with third parties if the Company Board determines it is necessary to fulfill fiduciary duties.",
        "clause_text": "Notwithstanding anything to the contrary contained in Section 5.5(a), if at any time following the date hereof and prior to the receipt of the Company Shareholder Approval (i) the Company has received a bona fide written Competing Proposal from a Third Party, (ii) the Company has not breached this Section 5.5 in any material respect with respect to such Competing Proposal and (iii) the Company Board determines in good faith, after consultation with its financial advisors and outside counsel, based on information then available, that the failure to take any of the following actions would be reasonably likely to be inconsistent with the fiduciary duties of the members of the Company Board to the Company's shareholders under the Law of the Cayman Islands and that such Competing Proposal constitutes or would reasonably be expected to lead to a Superior Proposal, then the Company and its Representatives may, directly or indirectly through the Company's Representatives: (A) furnish information with respect to the Company and its Subsidiaries (including non-public information) to the Third Party making such Competing Proposal and its Representatives pursuant to (but only pursuant to) one or more Acceptable Confidentiality Agreements and (B) participate or engage in discussions or negotiations with the Third Party making such Competing Proposal and its Representatives regarding such Competing Proposal and any changes thereto, including by making counterproposals thereto; provided, however, that any substantive non-public information concerning the Company or its Subsidiaries provided or made available to any Third Party shall, to the extent not previously provided or made available to Parent or Merger Sub, be provided or made available to Parent or Merger Sub as promptly as reasonably practicable (and in any event within forty-eight (48) hours) after it is provided or made available to such Third Party, except to the extent providing Parent or Merger Sub with such information would violate any applicable Law.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (c)"
      }
    ],
    "match_right": [
      {
        "section": "non_solicitation",
        "field_name": "match_right_initial_included",
        "answer": true,
        "summary": "The agreement grants the buyer a right to match an initial Superior Proposal received by the target.",
        "confidence": 0.9,
        "reason": "The agreement provides a 'Matching Period' during which the Company must engage in good faith discussions and negotiations with Parent regarding a possible amendment to the Agreement.",
        "clause_text": "during the period commencing on the date of Parent's receipt of the Company Intervening Event Notice and ending at 5:00 p.m. Taiwan time on the date that is the fourth (4th) Business Day thereafter (the 'Matching Period'), has made its Representatives reasonably available to engage, and the Company has, engaged, in good faith discussions and negotiations with Parent and its Representatives (to the extent Parent desired to negotiate) regarding a possible amendment to this Agreement and has considered in good faith any proposals made by Parent",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (e)"
      },
      {
        "section": "non_solicitation",
        "field_name": "match_right_initial_explanation",
        "answer": "The Company has provided Parent with a written notice (a \"Company Notice\") of such determination stating that such notice constitutes a Company Notice, stating whether the Company Board intends to effect a Company Change of Recommendation or the Company intends to terminate this Agreement, and describing in reasonable detail the reason for such Company Change of Recommendation or termination; provided, that the sole action of giving such Company Notice and of the Company Board in authorizing and disclosing (to the extent legally required) such Company Notice shall not constitute a Company Change of Recommendation, a violation of this Section 5.5 or a termination of this Agreement, (iii) the Company has provided Parent with all agreements and documents, and a copy of all material written communications, relating to such Competing Proposal, (iv) during the period commencing on delivery of the Company Notice to Parent and ending at 5:00 p.m. Taiwan time on the date that is the fourth (4th) Business Day after such delivery, the Company has made its Representatives reasonably available for the purpose of engaging, and the Company has, engaged, in good faith discussions and negotiations with Parent and its Representatives (to the extent Parent desired to negotiate) regarding a possible amendment to this Agreement and has considered in good faith any written proposals made by Parent that if accepted by the Company would be binding upon Parent, and after taking account of Parent's proposals, if any, the Company Board again makes the determination set forth in Section 5.5(f)(i).",
        "summary": "The Company must provide Parent with a written notice of a Superior Proposal and engage in good faith negotiations for four business days to allow Parent to amend its offer.",
        "confidence": 0.9,
        "reason": "The clause specifies a four business day negotiation period and the requirement for written notice to Parent, fulfilling the criteria for a matching right.",
        "clause_text": "The Company has provided Parent with a written notice (a \"Company Notice\") of such determination stating that such notice constitutes a Company Notice, stating whether the Company Board intends to effect a Company Change of Recommendation or the Company intends to terminate this Agreement, and describing in reasonable detail the reason for such Company Change of Recommendation or termination; provided, that the sole action of giving such Company Notice and of the Company Board in authorizing and disclosing (to the extent legally required) such Company Notice shall not constitute a Company Change of Recommendation, a violation of this Section 5.5 or a termination of this Agreement, (iii) the Company has provided Parent with all agreements and documents, and a copy of all material written communications, relating to such Competing Proposal, (iv) during the period commencing on delivery of the Company Notice to Parent and ending at 5:00 p.m. Taiwan time on the date that is the fourth (4th) Business Day after such delivery, the Company has made its Representatives reasonably available for the purpose of engaging, and the Company has, engaged, in good faith discussions and negotiations with Parent and its Representatives (to the extent Parent desired to negotiate) regarding a possible amendment to this Agreement and has considered in good faith any written proposals made by Parent that if accepted by the Company would be binding upon Parent, and after taking account of Parent's proposals, if any, the Company Board again makes the determination set forth in Section 5.5(f)(i).",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (f)"
      },
      {
        "section": "non_solicitation",
        "field_name": "match_right_amended_included",
        "answer": true,
        "summary": "The agreement provides that if the financial or other material terms of a Competing Proposal are amended, the Company must deliver a new notice to Parent, allowing for a renewed negotiation period.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that a new notice must be delivered if the terms of a Competing Proposal are amended, indicating a renewed right to match.",
        "clause_text": "Following receipt by Parent of a Company Notice, if the financial or other material terms of such Competing Proposal are amended prior to the Company Board making a Company Change of Recommendation or terminating this Agreement in accordance with the foregoing sentence, the Company will deliver to Parent a new Company Notice prior to the Company Board making a Company Change of Recommendation or terminating this Agreement in accordance with the foregoing sentence.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (f)"
      },
      {
        "section": "non_solicitation",
        "field_name": "match_right_amended_explanation",
        "answer": "The agreement permits the Buyer to respond to a modified or revised Superior Proposal by providing a new Company Notice and a new negotiation period of three (3) Business Days.",
        "summary": "The Buyer is allowed to respond to a modified or revised Superior Proposal by receiving a new Company Notice and engaging in a new negotiation period of three Business Days.",
        "confidence": 0.9,
        "reason": "The agreement explicitly mentions a new Company Notice and a new negotiation period of three Business Days for the Buyer to respond to a modified or revised Superior Proposal.",
        "clause_text": "Following receipt by Parent of a Company Notice, if the financial or other material terms of such Competing Proposal are amended prior to the Company Board making a Company Change of Recommendation or terminating this Agreement in accordance with the foregoing sentence, the Company will deliver to Parent a new Company Notice prior to the Company Board making a Company Change of Recommendation or terminating this Agreement in accordance with the foregoing sentence; provided, that the period of negotiation provided in Section 5.5(f)(iv)(the \"Notice Period\") shall instead end at 5:00 p.m. Taiwan time on the third (3rd) Business Day immediately following delivery of such Company Notice, but no such new Company Notice shall shorten the original fourth (4th) Business Day period, and there may be multiple new Notice Periods if there are multiple revisions in price or other material revisions in terms or other material changes.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (f)"
      }
    ],
    "adverse_recommendation_change": [
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_superior_proposal_included",
        "answer": true,
        "summary": "The board of directors is permitted to make a Company Change of Recommendation in response to a Superior Proposal.",
        "confidence": 0.9,
        "reason": "The document explicitly states that the Company Board may make a Company Change of Recommendation in response to a Superior Proposal.",
        "clause_text": "Notwithstanding anything to the contrary contained in this Section 5.5, at any time prior to the receipt of the Company Shareholder Approval, the Company Board may in response to its receipt after the date of this Agreement of a bona fide written Competing Proposal with respect to which the Company is not in material breach of this Section 5.5, make a Company Change of Recommendation or terminate this Agreement to enter into a definitive written agreement providing for such Competing Proposal pursuant to Section 7.1(f) if, and only if, (i) the Company Board has determined in good faith after consultation with the Company's outside counsel and financial advisor that (x) such Competing Proposal constitutes a Superior Proposal...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (f)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_superior_proposal_explanation",
        "answer": "The Company Board is permitted to change its recommendation in response to a Superior Proposal if it determines in good faith, after consultation with its financial advisors and outside counsel, that such Competing Proposal constitutes a Superior Proposal and that failure to change the recommendation would be inconsistent with fiduciary duties.",
        "summary": "The Company Board may change its recommendation in response to a Superior Proposal if it determines in good faith, after consulting with advisors, that not doing so would breach fiduciary duties.",
        "confidence": 0.9,
        "reason": "The clause explicitly allows the Company Board to change its recommendation if a Superior Proposal is received and not changing would breach fiduciary duties.",
        "clause_text": "Notwithstanding anything to the contrary contained in this Section 5.5, at any time prior to the receipt of the Company Shareholder Approval, the Company Board may in response to its receipt after the date of this Agreement of a bona fide written Competing Proposal with respect to which the Company is not in material breach of this Section 5.5, make a Company Change of Recommendation or terminate this Agreement to enter into a definitive written agreement providing for such Competing Proposal pursuant to Section 7.1(f) if, and only if, (i) the Company Board has determined in good faith after consultation with the Company's outside counsel and financial advisor that (x) such Competing Proposal constitutes a Superior Proposal, after giving effect to all of the adjustments to the terms of this Agreement which may have been offered by Parent on a binding basis prior to the determination by the Company Board, and (y) the failure to make such Company Change of Recommendation or to terminate this Agreement would be reasonably likely to be inconsistent with the fiduciary duties of the members of the Company Board to the Company's shareholders under the Law of the Cayman Islands;",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (f)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_intervening_event_included",
        "answer": true,
        "summary": "The Company Board is permitted to make a Company Change of Recommendation in response to a Company Intervening Event if certain conditions are met.",
        "confidence": 0.9,
        "reason": "The agreement explicitly allows for a Company Change of Recommendation in response to a Company Intervening Event, which is defined as an event not related to a Competing Proposal.",
        "clause_text": "Notwithstanding anything to the contrary contained in this Section 5.5, at any time prior to the receipt of the Company Shareholder Approval, the Company Board may make a Company Change of Recommendation in response to a Company Intervening Event if, and only if, (i) the Company Board has determined in good faith after consultation with the Company's outside counsel and financial advisor that the failure to make a Company Change of Recommendation would be reasonably likely to be inconsistent with the fiduciary duties of the members of the Company Board to the Company's shareholders under the Law of the Cayman Islands...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (e)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_intervening_event_explanation",
        "answer": "The Company Board may make a Company Change of Recommendation in response to a Company Intervening Event if it determines in good faith that failure to do so would be inconsistent with its fiduciary duties, provided it follows specific procedures including notifying Parent and engaging in discussions.",
        "summary": "The Company Board can change its recommendation due to a Company Intervening Event if it determines in good faith that not doing so would breach fiduciary duties, after notifying Parent and engaging in discussions.",
        "confidence": 0.9,
        "reason": "The clause explicitly allows for a change in recommendation due to an Intervening Event, with specific procedural requirements.",
        "clause_text": "(e) Notwithstanding anything to the contrary contained in this Section 5.5, at any time prior to the receipt of the Company Shareholder Approval, the Company Board may make a Company Change of Recommendation in response to a Company Intervening Event if, and only if, (i) the Company Board has determined in good faith after consultation with the Company's outside counsel and financial advisor that the failure to make a Company Change of Recommendation would be reasonably likely to be inconsistent with the fiduciary duties of the members of the Company Board to the Company's shareholders under the Law of the Cayman Islands; provided, that the making of such determination shall not in and of itself constitute a Company Change of Recommendation or violation of this Section 5.5, (ii) the Company has provided Parent with a written notice (a \"Company Intervening Event Notice\") of such determination, stating that such notice constitutes a Company Intervening Event Notice, providing a description of the material facts and circumstances giving rise to a Company Intervening Event, and that the Company Board intends to effect a Company Change of Recommendation; provided, that the sole action of giving such Company Intervening Event Notice and the of the Company Board authorizing and disclosing (to the extent legally required) such Company Intervening Event Notice shall not constitute a Company Change of Recommendation or a violation of this Section 5.5); and (iii) during the period commencing on the date of Parent's receipt of the Company Intervening Event Notice and ending at 5:00 p.m. Taiwan time on the date that is the fourth (4th) Business Day thereafter (the \"Matching Period\"), has made its Representatives reasonably available to engage, and the Company has, engaged, in good faith discussions and negotiations with Parent and its Representatives (to the extent Parent desired to negotiate) regarding a possible amendment to this Agreement and has considered in good faith any proposals made by Parent, and after taking account of Parent's proposals, if any, the Company Board again makes the determination set forth in Section 5.5(e)(i).",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (e)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_timing",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "go_shop": [
      {
        "section": "non_solicitation",
        "field_name": "go_shop_included",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "non_solicitation",
        "field_name": "go_shop_explanation",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "standstill_waiver_restriction": [
      {
        "section": "non_solicitation",
        "field_name": "standstill_waiver_restriction_included",
        "answer": true,
        "summary": "The agreement prohibits the Company from waiving, terminating, or modifying any confidentiality, standstill, or similar provision without Parent's prior written consent, except under specific fiduciary duty circumstances.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that the Company shall enforce and not waive, terminate, or modify any confidentiality, standstill, or similar provision without Parent's prior written consent.",
        "clause_text": "The Company shall enforce, and not waive, terminate, or modify without Parent's prior written consent, any confidentiality, standstill or similar provision in any confidentiality, standstill or other agreement; provided that, if the Company Board determines in good faith after consultation with the Company's outside legal counsel that the failure to waive a particular standstill provision, or other provision with similar effect, would reasonably likely to be inconsistent with the fiduciary duties of the members of the Company Board to the Company's shareholders under the Law of the Cayman Islands, the Company may, with prior written notice to Parent, waive such standstill provision, or other provision with similar effect.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (b)"
      },
      {
        "section": "non_solicitation",
        "field_name": "standstill_waiver_restriction_explanation",
        "answer": "The Company shall enforce, and not waive, terminate, or modify without Parent's prior written consent, any confidentiality, standstill or similar provision in any confidentiality, standstill or other agreement; provided that, if the Company Board determines in good faith after consultation with the Company's outside legal counsel that the failure to waive a particular standstill provision, or other provision with similar effect, would reasonably likely to be inconsistent with the fiduciary duties of the members of the Company Board to the Company's shareholders under the Law of the Cayman Islands, the Company may, with prior written notice to Parent, waive such standstill provision, or other provision with similar effect.",
        "summary": "The Company cannot waive standstill agreements without Parent's consent unless the Company Board determines it conflicts with fiduciary duties, in which case prior notice to Parent is required.",
        "confidence": 0.9,
        "reason": "The clause explicitly outlines conditions under which the Company can waive standstill provisions, linking it to fiduciary duties.",
        "clause_text": "The Company shall enforce, and not waive, terminate, or modify without Parent's prior written consent, any confidentiality, standstill or similar provision in any confidentiality, standstill or other agreement; provided that, if the Company Board determines in good faith after consultation with the Company's outside legal counsel that the failure to waive a particular standstill provision, or other provision with similar effect, would reasonably likely to be inconsistent with the fiduciary duties of the members of the Company Board to the Company's shareholders under the Law of the Cayman Islands, the Company may, with prior written notice to Parent, waive such standstill provision, or other provision with similar effect.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (b)"
      }
    ],
    "superior_proposal": [
      {
        "section": "non_solicitation",
        "field_name": "superior_proposal_definition",
        "answer": "A 'Superior Proposal' is a bona fide written offer from a Third Party constituting a Competing Proposal, which the Company Board determines in good faith to be more favorable to the shareholders of the Company from a financial point of view than the Merger, taking into account factors such as terms and conditions, identity of the offeror, financing conditions, likelihood and timing of consummation, and any proposals by Parent.",
        "summary": "A 'Superior Proposal' is a bona fide offer deemed more favorable to shareholders than the current Merger, considering financial and non-financial factors.",
        "confidence": 0.95,
        "reason": "The definition explicitly outlines the criteria for a proposal to be considered superior, including financial favorability and other relevant factors.",
        "clause_text": "\"Superior Proposal\" means a bona fide written offer from a Third Party (on its most recently amended or modified terms, if amended or modified) constituting a Competing Proposal (with references to 15% and 85% being deemed to be replaced with references to 50%), which the Company Board determines in good faith after consultation with the Company's outside counsel and financial advisors to be more favorable to the shareholders of the Company from a financial point of view than the Merger, taking into account such other factors as the Company Board considers in good faith to be appropriate (including the terms and conditions of such offer, the identity of the Person or group making such offer, the existence of any financing conditions, the conditionality of any financing commitments, the likelihood and timing of consummation, and any proposals by Parent with respect to possible amendment to this Agreement that if accepted by the Company would be binding upon Parent).",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (i) > (iii)"
      }
    ],
    "buyer_diligence_access": [
      {
        "section": "non_solicitation",
        "field_name": "buyer_diligence_access_included",
        "answer": true,
        "summary": "The agreement grants the buyer the right to receive any diligence materials shared with a third party.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that any substantive non-public information provided to a third party must also be provided to the buyer.",
        "clause_text": "provided, however, that any substantive non-public information concerning the Company or its Subsidiaries provided or made available to any Third Party shall, to the extent not previously provided or made available to Parent or Merger Sub, be provided or made available to Parent or Merger Sub as promptly as reasonably practicable (and in any event within forty-eight (48) hours) after it is provided or made available to such Third Party.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (c)"
      },
      {
        "section": "non_solicitation",
        "field_name": "buyer_diligence_access_explanation",
        "answer": "any substantive non-public information concerning the Company or its Subsidiaries provided or made available to any Third Party shall, to the extent not previously provided or made available to Parent or Merger Sub, be provided or made available to Parent or Merger Sub as promptly as reasonably practicable (and in any event within forty-eight (48) hours) after it is provided or made available to such Third Party",
        "summary": "The Company is obligated to provide Parent with any substantive non-public information shared with a third party in connection with a Competing Proposal within 48 hours.",
        "confidence": 0.95,
        "reason": "The clause explicitly states the obligation to share non-public information with Parent if it is shared with a third party.",
        "clause_text": "any substantive non-public information concerning the Company or its Subsidiaries provided or made available to any Third Party shall, to the extent not previously provided or made available to Parent or Merger Sub, be provided or made available to Parent or Merger Sub as promptly as reasonably practicable (and in any event within forty-eight (48) hours) after it is provided or made available to such Third Party",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (c)"
      }
    ],
    "recommendation_change_restriction": [
      {
        "section": "non_solicitation",
        "field_name": "recommendation_change_restriction_included",
        "answer": true,
        "summary": "The agreement imposes restrictions on how and when the board of directors may communicate a change in its recommendation, requiring prior notice to the buyer and allowing for a negotiation period.",
        "confidence": 0.9,
        "reason": "The agreement specifies that the Company Board must provide Parent with a written notice of its determination to change its recommendation and engage in good faith discussions with Parent before making such a change.",
        "clause_text": "The Company has provided Parent with a written notice (a \"Company Notice\") of such determination stating that such notice constitutes a Company Notice, stating whether the Company Board intends to effect a Company Change of Recommendation or the Company intends to terminate this Agreement, and describing in reasonable detail the reason for such Company Change of Recommendation or termination; provided, that the sole action of giving such Company Notice and of the Company Board in authorizing and disclosing (to the extent legally required) such Company Notice shall not constitute a Company Change of Recommendation, a violation of this Section 5.5 or a termination of this Agreement.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (f)"
      },
      {
        "section": "non_solicitation",
        "field_name": "recommendation_change_restriction_explanation",
        "answer": "The agreement imposes procedural and timing-based restrictions on how the Company may change its recommendation.",
        "summary": "The Company must provide Parent with written notice of its determination to change its recommendation, engage in good faith discussions and negotiations with Parent during a specified period, and consider any proposals made by Parent before making a final decision.",
        "confidence": 0.9,
        "reason": "The agreement outlines specific steps and timing requirements for the Company to follow before changing its recommendation, indicating procedural restrictions.",
        "clause_text": "The Company has provided Parent with a written notice (a \"Company Notice\") of such determination stating that such notice constitutes a Company Notice, stating whether the Company Board intends to effect a Company Change of Recommendation or the Company intends to terminate this Agreement, and describing in reasonable detail the reason for such Company Change of Recommendation or termination; provided, that the sole action of giving such Company Notice and of the Company Board in authorizing and disclosing (to the extent legally required) such Company Notice shall not constitute a Company Change of Recommendation, a violation of this Section 5.5 or a termination of this Agreement, (iii) the Company has provided Parent with all agreements and documents, and a copy of all material written communications, relating to such Competing Proposal, (iv) during the period commencing on delivery of the Company Notice to Parent and ending at 5:00 p.m. Taiwan time on the date that is the fourth (4th) Business Day after such delivery, the Company has made its Representatives reasonably available for the purpose of engaging, and the Company has, engaged, in good faith discussions and negotiations with Parent and its Representatives (to the extent Parent desired to negotiate) regarding a possible amendment to this Agreement and has considered in good faith any written proposals made by Parent that if accepted by the Company would be binding upon Parent, and after taking account of Parent's proposals, if any, the Company Board again makes the determination set forth in Section 5.5(f)(i).",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (f)"
      }
    ]
  },
  "best_efforts": {
    "regulatory_efforts": [
      {
        "section": "best_efforts",
        "field_name": "effort_standard",
        "answer": "Reasonable Best Efforts",
        "summary": "The parties are required to use their reasonable best efforts to take all necessary actions to satisfy conditions to closing and obtain regulatory approvals.",
        "confidence": 0.9,
        "reason": "The term 'reasonable best efforts' is explicitly used multiple times in the context of regulatory efforts.",
        "clause_text": "Upon the terms and subject to the conditions set forth in this Agreement, each of the parties agrees to use its reasonable best efforts to (i) take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under this Agreement and applicable Law to cause the conditions to Closing to be satisfied as promptly as reasonably practicable...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "effort_scope",
        "answer": "RBE for HSR, FTC, DOJ, and SAMR filings",
        "summary": "The reasonable best efforts standard applies to filings and responses related to the HSR Act, FTC, DOJ, and SAMR.",
        "confidence": 0.9,
        "reason": "The clause explicitly mentions the HSR Act, FTC, DOJ, and SAMR in the context of regulatory filings and efforts.",
        "clause_text": "Parent and the Company shall use their respective reasonable best efforts to respond as promptly as reasonably practicable to any inquiries or requests for additional information or documentary material received from any state attorney general, antitrust authority or other Governmental Entity, including the Federal Trade Commission (the \"FTC\"), Antitrust Division of the U.S. Department of Justice (the \"DOJ\") and the People's Republic of China's State Administration for Market Regulation (\"SAMR\") in connection with the matters in Section 5.6(a) and this Section 5.6(b).",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (b)"
      }
    ],
    "regulatory_fillings_hsr": [
      {
        "section": "best_efforts",
        "field_name": "hsr_required",
        "answer": true,
        "summary": "The expiration or termination of the HSR waiting period is a condition to closing the merger.",
        "confidence": 0.95,
        "reason": "The document explicitly states that the expiration or termination of the HSR waiting period is a condition to the consummation of the merger.",
        "clause_text": "The respective obligations of each party to consummate the Merger shall be subject to the satisfaction (or waiver, if permissible under Law) at or prior to the Effective Time of each of the following conditions: ... (d) Any applicable waiting period, together with any extensions thereof, under the HSR Act shall have expired or been terminated.",
        "reference_section": "ARTICLE Article 6 Conditions to Consummation of the Merger > Section 6.1 Conditions to Obligations of Each Party Under This Agreement > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "hsr_filing_deadline_days",
        "answer": 15,
        "summary": "The parties are required to file the pre-merger notification under the HSR Act no later than fifteen Business Days after execution of the Agreement.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the deadline for filing the pre-merger notification under the HSR Act.",
        "clause_text": "In furtherance and not in limitation of the foregoing, each party hereto shall, in consultation and cooperation with the other: (i) prepare and file the pre-merger notification under the HSR Act as promptly as practicable but in no case later than fifteen (15) Business Days after execution of this Agreement unless otherwise agreed by the parties.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (b) > (i)"
      },
      {
        "section": "best_efforts",
        "field_name": "hsr_notes",
        "answer": "Must file pre-merger notification under the HSR Act as promptly as practicable but in no case later than 15 Business Days after execution of this Agreement.",
        "summary": "The parties must file the pre-merger notification under the HSR Act within 15 Business Days after executing the Agreement.",
        "confidence": 0.9,
        "reason": "The document specifies a clear deadline for filing the pre-merger notification under the HSR Act.",
        "clause_text": "In furtherance and not in limitation of the foregoing, each party hereto shall, in consultation and cooperation with the other: (i) prepare and file the pre-merger notification under the HSR Act as promptly as practicable but in no case later than fifteen (15) Business Days after execution of this Agreement unless otherwise agreed by the parties.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (b) > (i)"
      }
    ],
    "regulatory_fillings_cfiius": [
      {
        "section": "best_efforts",
        "field_name": "cfiius_required",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "cfiius_filing_deadline_days",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "cfiius_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "regulatory_fillings_foreign": [
      {
        "section": "best_efforts",
        "field_name": "foreign_filling_notes",
        "answer": "Foreign filings may be required under applicable non-U.S. laws",
        "summary": "Foreign filings may be required under applicable non-U.S. laws.",
        "confidence": 0.9,
        "reason": "The agreement refers to 'Regulatory Laws' which include Competition Laws and FDI Laws, encompassing foreign jurisdictions.",
        "clause_text": "Regulatory Laws means Competition Laws and FDI Laws.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Regulatory Laws"
      },
      {
        "section": "best_efforts",
        "field_name": "foreign_filling_required",
        "answer": true,
        "summary": "The agreement requires filings under non-U.S. antitrust or merger control laws, as it references obligations under 'other Regulatory Laws' and includes the People's Republic of China's State Administration for Market Regulation (SAMR) as a relevant authority.",
        "confidence": 0.9,
        "reason": "The inclusion of 'other Regulatory Laws' and specific mention of SAMR implies the necessity for foreign filings.",
        "clause_text": "Parent and the Company shall use their respective reasonable best efforts to respond as promptly as reasonably practicable to any inquiries or requests for additional information or documentary material received from any state attorney general, antitrust authority or other Governmental Entity, including the Federal Trade Commission (the \"FTC\"), Antitrust Division of the U.S. Department of Justice (the \"DOJ\") and the People's Republic of China's State Administration for Market Regulation (\"SAMR\") in connection with the matters in Section 5.6(a) and this Section 5.6(b).",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (b)"
      },
      {
        "section": "best_efforts",
        "field_name": "foreign_filling_deadline_days",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "divestiture_commitments": [
      {
        "section": "best_efforts",
        "field_name": "divestiture_required",
        "answer": true,
        "summary": "The agreement allows for conduct remedies, such as behavior or conduct remedies, to obtain regulatory approvals, but does not require structural remedies like divestitures.",
        "confidence": 0.9,
        "reason": "The agreement specifies that Parent and its affiliates agree to use reasonable best efforts to obtain all approvals or clearances, including committing to undertake behavior or conduct remedies.",
        "clause_text": "Parent and its affiliates agree to use reasonable best efforts to obtain all approvals or clearances of the Merger or the Transactions required pursuant to applicable Regulatory Laws... including Parent or any of its affiliates committing to undertake behavior or conduct remedies with respect to the Company or its Subsidiaries.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (f)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_value",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_unit",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_basis",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_basis_scope",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_clause_reference",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_value",
        "answer": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (f)",
        "summary": "The clause outlines the obligations of Parent and its affiliates to use reasonable best efforts to obtain necessary approvals or clearances for the Merger or Transactions under applicable Regulatory Laws.",
        "confidence": 0.9,
        "reason": "The clause specifies the efforts required by Parent and its affiliates to secure regulatory approvals, which is relevant to divestiture commitments.",
        "clause_text": "In furtherance to and not in limitation of the foregoing, Parent and its affiliates agree to use reasonable best efforts to obtain all approvals or clearances of the Merger or the Transactions required pursuant to applicable Regulatory Laws or the expiration or termination of any applicable waiting periods (and any extension thereof) in connection therewith in order for the parties hereto to consummate the Transactions as promptly as reasonably practicable and in any event prior to the Outside Date (as the same may be extended), and to avoid any impediment to the consummation of the Merger of the Transactions, including Parent or any of its affiliates committing to undertake behavior or conduct remedies with respect to the Company or its Subsidiaries, in each case, as may be required in order to avoid the entry of, or to effect the lifting or dissolution of, any injunction, temporary restraining order, or other Order in any suit or Proceeding, which would otherwise have the effect of preventing the Closing, in order for the parties hereto to consummate the Transactions as promptly as reasonably practicable and in any event prior to the Outside Date (as the same may be extended).",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (f)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_unit",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_basis",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_basis_scope",
        "answer": "Parent",
        "summary": "The divestiture cap applies to the operations or assets of the Parent or its affiliates.",
        "confidence": 0.9,
        "reason": "The agreement refers to Parent and its affiliates in the context of divestiture commitments.",
        "clause_text": "Notwithstanding the foregoing or anything else herein to the contrary, it is expressly understood and agreed that none of Parent or any of its affiliates shall be required to propose, negotiate, commit to or effect, execute or carry out agreements, enter into consent decrees or submit to orders providing for, whether by consent decree, national security agreement, letter of assurance, hold separate orders, or otherwise (A) to sell, divest, lease, license, transfer, dispose of, hold separate (through establishment of a trust or otherwise) or otherwise encumber, limit or impair or take any other action with respect to Parent's or any of its affiliates' or the Company's or and of its Subsidiary's ability to own or operate any assets or categories of assets, properties, businesses or product lines of Parent or any of its affiliates or the Company or any of its Subsidiaries...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (f)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_notes",
        "answer": "Parent is not required to divest any of its businesses.",
        "summary": "Parent is not required to divest any of its businesses or assets to obtain regulatory approvals for the merger.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that Parent is not required to sell, divest, or otherwise encumber its assets or businesses.",
        "clause_text": "Notwithstanding the foregoing or anything else herein to the contrary, it is expressly understood and agreed that none of Parent or any of its affiliates shall be required to propose, negotiate, commit to or effect, execute or carry out agreements, enter into consent decrees or submit to orders providing for, whether by consent decree, national security agreement, letter of assurance, hold separate orders, or otherwise (A) to sell, divest, lease, license, transfer, dispose of, hold separate (through establishment of a trust or otherwise) or otherwise encumber, limit or impair or take any other action with respect to Parent's or any of its affiliates' or the Company's or and of its Subsidiary's ability to own or operate any assets or categories of assets, properties, businesses or product lines of Parent or any of its affiliates or the Company or any of its Subsidiaries, even if required in order to avoid the entry of, or to effect the lifting or dissolution of, any injunction, temporary restraining order, or other Order in any suit or Proceeding.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (f)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_clause_reference",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_scope_exclusions",
        "answer": [],
        "summary": "No specific business units, divisions, assets, or categories are explicitly excluded from divestiture or Remedy Actions in the provided excerpts.",
        "confidence": 0.9,
        "reason": "The excerpts do not mention any exclusions related to divestiture or Remedy Actions.",
        "clause_text": "Excluded Shares means, collectively (a) Shares (including Shares represented by ADSs) held by Parent, the Company or any of their Subsidiaries and (b) any Shares (including ADSs corresponding to such Shares) held by the Depositary and reserved for issuance and allocation pursuant to the Company Equity Plans.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Excluded Shares"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_clause_summary",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_clause_summary_clause_reference",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "litigation_commitments": [
      {
        "section": "best_efforts",
        "field_name": "litigation_requirement_status",
        "answer": "Explicit Requirement to Litigate",
        "summary": "The agreement requires the parties to defend lawsuits or other legal proceedings challenging the merger or its consummation.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the obligation to defend lawsuits or legal proceedings related to the merger.",
        "clause_text": "to defend lawsuits or other legal proceedings, whether judicial or administrative, challenging this Agreement or the consummation of the Merger and the other Transactions.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "litigation_clause_scope",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "required_to_litigate_notes",
        "answer": "Buyer must litigate regulatory challenges unless conditions to closing are impossible.",
        "summary": "Buyer must litigate regulatory challenges unless conditions to closing are impossible.",
        "confidence": 0.9,
        "reason": "The clause specifies that parties must use reasonable best efforts to defend lawsuits challenging the merger, but does not require litigation if conditions to closing are impossible.",
        "clause_text": "each of the parties agrees to use its reasonable best efforts to (i) take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under this Agreement and applicable Law to cause the conditions to Closing to be satisfied as promptly as reasonably practicable ... (iv) to defend lawsuits or other legal proceedings, whether judicial or administrative, challenging this Agreement or the consummation of the Merger and the other Transactions.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (a)"
      }
    ],
    "withdrawal_and_timing_controls_withdrawal": [
      {
        "section": "best_efforts",
        "field_name": "withdrawal_control_type",
        "answer": "buyer_only",
        "summary": "The agreement specifies that the Parent shall have full control over devising the strategy and tactics for obtaining clearances, approvals, and waiting-period expirations under Regulatory Laws.",
        "confidence": 0.9,
        "reason": "The language in Section 5.6(e) explicitly grants the Parent full control over regulatory strategies, indicating buyer-only control over withdrawal.",
        "clause_text": "Notwithstanding the foregoing or anything else herein to the contrary, the parties agree that Parent shall have full control over devising the strategy and tactics for obtaining clearances, approvals and waiting-period expirations under Regulatory Laws, including any filings, notifications, submissions and communications with or to any Governmental Entity in connection therewith; provided that Parent shall reasonably consider any good faith proposals timely made by the Company or its legal counsel.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (e)"
      },
      {
        "section": "best_efforts",
        "field_name": "withdrawal_control_type_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "withdrawal_and_timing_controls_timing": [
      {
        "section": "best_efforts",
        "field_name": "timing_agreement_restriction",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "timing_agreement_restriction_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "remedy_actions_other": [
      {
        "section": "best_efforts",
        "field_name": "remedy_definitions_provided",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "remedy_definition_text",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "remedy_definition_text_clause_reference",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "transaction_interference": [
      {
        "section": "best_efforts",
        "field_name": "restriction_on_other_transactions",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "interference_clause_text",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "interference_clause_text_clause_reference",
        "answer": "Section 5.6",
        "summary": "Section 5.6 outlines the obligations of the parties to use reasonable best efforts to avoid actions that could delay or obstruct regulatory review or merger clearance.",
        "confidence": 0.9,
        "reason": "The section explicitly details the parties' commitments to regulatory cooperation and avoiding interference with the merger process.",
        "clause_text": "Each party hereto agrees to use its reasonable best efforts to file, as soon as practicable and advisable after the date of this Agreement, all applications, notices, petitions and filings required or recommended to be filed by such party with any Governmental Entity with respect to the Merger and the other Transactions, and to submit as promptly as reasonably practicable any additional information requested by any such Governmental Entity.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (b)"
      }
    ],
    "second_request_certification": [
      {
        "section": "best_efforts",
        "field_name": "second_request_certification_deadline_specified",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "second_request_certification_certification_timeline_notes",
        "answer": "as promptly as reasonably practicable",
        "summary": "The agreement requires parties to use reasonable best efforts to prepare and file all necessary documentation for regulatory compliance, including HSR Act filings, as promptly as reasonably practicable.",
        "confidence": 0.9,
        "reason": "The phrase 'as promptly as reasonably practicable' is used in the context of regulatory filings, which includes HSR Act compliance.",
        "clause_text": "Each party hereto agrees to use its reasonable best efforts to file, as soon as practicable and advisable after the date of this Agreement, all applications, notices, petitions and filings required or recommended to be filed by such party with any Governmental Entity with respect to the Merger and the other Transactions, and to submit as promptly as reasonably practicable any additional information requested by any such Governmental Entity.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (b)"
      },
      {
        "section": "best_efforts",
        "field_name": "second_request_certification_responsibility_party",
        "answer": "Both",
        "summary": "Both parties are required to use their reasonable best efforts to file necessary documentation and respond to requests under the HSR Act, indicating shared responsibility for compliance certification.",
        "confidence": 0.9,
        "reason": "The agreement specifies that each party must use reasonable best efforts to prepare and file necessary documentation under the HSR Act, implying joint responsibility.",
        "clause_text": "Each party hereto agrees to use its reasonable best efforts to file, as soon as practicable and advisable after the date of this Agreement, all applications, notices, petitions and filings required or recommended to be filed by such party with any Governmental Entity with respect to the Merger and the other Transactions, and to submit as promptly as reasonably practicable any additional information requested by any such Governmental Entity.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (b)"
      }
    ],
    "ftc_warning_letter_handling": [
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_addressed",
        "answer": true,
        "summary": "The agreement explicitly mentions the handling of communications with the FTC, including responses to inquiries or requests for additional information.",
        "confidence": 0.9,
        "reason": "The agreement includes provisions for responding to inquiries or requests for additional information from the FTC, indicating handling of preliminary regulatory communications.",
        "clause_text": "Parent and the Company shall use their respective reasonable best efforts to respond as promptly as reasonably practicable to any inquiries or requests for additional information or documentary material received from any state attorney general, antitrust authority or other Governmental Entity, including the Federal Trade Commission (the 'FTC'), Antitrust Division of the U.S. Department of Justice (the 'DOJ') and the People's Republic of China's State Administration for Market Regulation ('SAMR') in connection with the matters in Section 5.6(a) and this Section 5.6(b).",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (b)"
      },
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_notes",
        "answer": "Not addressed",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_effect_on_closing_condition",
        "answer": "Silent",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_addressed_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "other_timing_controls": [
      {
        "section": "best_efforts",
        "field_name": "other_timing_controls_deadlines_specified",
        "answer": [
          "Parent shall prepare and file with the SEC a preliminary Form S-4 within 45 days after the date of this Agreement.",
          "The Company will cause the Form S-4 and the Proxy Statement to be mailed to its shareholders within 5 Business Days of the date the Form S-4 is declared effective by the SEC.",
          "The Company will hold a meeting of the Company shareholders within 45 days following the mailing of the Proxy Statement and the Form S-4, unless a later date is consented to by Parent."
        ],
        "summary": "The agreement specifies deadlines for filing the Form S-4, mailing it to shareholders, and holding a shareholder meeting.",
        "confidence": 0.95,
        "reason": "The agreement explicitly states deadlines for the Form S-4 filing, mailing, and shareholder meeting.",
        "clause_text": "As promptly as reasonably practicable following the date of this Agreement and in any event within forty-five (45) days after the date of this Agreement: (i) Parent shall prepare and file with the SEC a preliminary Form S-4. (b) The Company will cause the Form S-4 and the Proxy Statement to be mailed to its shareholders within five (5) Business Days of the date the Form S-4 is declared effective by the SEC. (e) The Company will, in accordance with the memorandum and articles of association of the Company, the Deposit Agreement, the CICA and all other applicable Laws, as promptly as practicable following the clearance of the Form S-4 by the SEC and in any event within forty-five (45) days following the mailing of the Proxy Statement and the Form S-4 (or such later date that Parent provides its prior written consent), hold a meeting of the Company shareholders (the 'Company Meeting') for the purpose of seeking the Company Shareholder Approval;",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (a), (b), (e)"
      }
    ],
    "novel_or_unstructured_regulatory_clauses": [
      {
        "section": "best_efforts",
        "field_name": "novel_or_unstructured_regulatory_clauses_items",
        "answer": [
          {
            "summary": "Parent has full control over the strategy and tactics for obtaining regulatory clearances, but must consider good faith proposals from the Company.",
            "section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (e)",
            "review_required": true
          },
          {
            "summary": "Parent is not required to take actions that would materially affect its or the Company's ability to own or operate assets, even if necessary to avoid regulatory injunctions.",
            "section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (f)",
            "review_required": true
          },
          {
            "summary": "Parent is restricted from engaging in M&A Activity that could delay or prevent regulatory approvals, except for acquisitions in China with annual revenue under $30 million.",
            "section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (g)",
            "review_required": true
          }
        ],
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "prior_approval_commitment": [
      {
        "section": "best_efforts",
        "field_name": "prior_approval_commitment_addressed",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "prior_approval_commitment_obligations_summary",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "prior_approval_commitment_clause_reference",
        "answer": "Section 5.6(g)",
        "summary": "Section 5.6(g) contains restrictions on Parent and Merger Sub's M&A activities that could delay or prevent obtaining necessary approvals for the current merger.",
        "confidence": 0.9,
        "reason": "Section 5.6(g) explicitly restricts Parent and Merger Sub from engaging in M&A activities that could materially delay or prevent obtaining necessary approvals for the merger.",
        "clause_text": "Neither Parent nor Merger Sub shall directly or indirectly acquire or agree to acquire (by merging or consolidating with, or by purchasing a substantial portion of the assets of or equity in, or by any other manner), any Person or portion thereof, or otherwise acquire or agree to acquire any assets (collectively, \"M&A Activity\"), if the entering into a definitive agreement relating to, or the consummation of, such acquisition, merger or consolidation would reasonably be expected to (A) impose any material delay in the obtaining of, or materially increase the risk of not obtaining, any permits, orders or other approvals of any Governmental Entity necessary to consummate the Transactions or the expiration or termination of any applicable waiting period, (B) materially increase the risk of any Governmental Entity seeking an Order prohibiting the consummation of the Transactions, (C) materially increase the risk of not being able to remove any such Order on appeal or otherwise, or (D) prevent the consummation of the Transactions by the Outside Date.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (g)"
      }
    ],
    "regulatory_process_control_discretion": [
      {
        "section": "best_efforts",
        "field_name": "regulatory_process_control_discretion",
        "answer": "Parent",
        "summary": "Parent has full control over devising the strategy and tactics for obtaining clearances, approvals, and waiting-period expirations under Regulatory Laws.",
        "confidence": 0.95,
        "reason": "The agreement explicitly states that Parent shall have full control over regulatory strategy and tactics.",
        "clause_text": "Notwithstanding the foregoing or anything else herein to the contrary, the parties agree that Parent shall have full control over devising the strategy and tactics for obtaining clearances, approvals and waiting-period expirations under Regulatory Laws, including any filings, notifications, submissions and communications with or to any Governmental Entity in connection therewith; provided that Parent shall reasonably consider any good faith proposals timely made by the Company or its legal counsel.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (e)"
      },
      {
        "section": "best_efforts",
        "field_name": "parent_has_sole_discretion_excluding_remedies",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "no_limitations_on_buyer_remedies": [
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_value",
        "answer": false,
        "summary": "The agreement places express limitations on the Buyer's obligation to take Remedy Actions, including not requiring Parent or its affiliates to sell, divest, or take other actions with respect to assets or businesses.",
        "confidence": 0.9,
        "reason": "The agreement explicitly states that Parent and its affiliates are not required to propose, negotiate, or effect certain actions, such as selling or divesting assets, to obtain regulatory approval.",
        "clause_text": "Notwithstanding the foregoing or anything else herein to the contrary, it is expressly understood and agreed that none of Parent or any of its affiliates shall be required to propose, negotiate, commit to or effect, execute or carry out agreements, enter into consent decrees or submit to orders providing for, whether by consent decree, national security agreement, letter of assurance, hold separate orders, or otherwise (A) to sell, divest, lease, license, transfer, dispose of, hold separate (through establishment of a trust or otherwise) or otherwise encumber, limit or impair or take any other action with respect to Parent's or any of its affiliates' or the Company's or and of its Subsidiary's ability to own or operate any assets or categories of assets, properties, businesses or product lines of Parent or any of its affiliates or the Company or any of its Subsidiaries, even if required in order to avoid the entry of, or to effect the lifting or dissolution of, any injunction, temporary restraining order, or other Order in any suit or Proceeding, (B) undertake any behavior or conduct remedy that would be material to Parent and its Subsidiaries (assuming consummation of the Transactions), taken as a whole, or (C) to take any action or make any omission that would violate applicable Law.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (f)"
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_inferred_hohw",
        "answer": false,
        "summary": "The agreement contains material carveouts and qualifications that prevent the inference of a Hell-or-High-Water obligation for the Buyer.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that Parent is not required to undertake certain actions that would be material to Parent and its Subsidiaries, indicating a limitation on Buyer remedies.",
        "clause_text": "Notwithstanding the foregoing or anything else herein to the contrary, it is expressly understood and agreed that none of Parent or any of its affiliates shall be required to propose, negotiate, commit to or effect, execute or carry out agreements, enter into consent decrees or submit to orders providing for, whether by consent decree, national security agreement, letter of assurance, hold separate orders, or otherwise (A) to sell, divest, lease, license, transfer, dispose of, hold separate (through establishment of a trust or otherwise) or otherwise encumber, limit or impair or take any other action with respect to Parent's or any of its affiliates' or the Company's or and of its Subsidiary's ability to own or operate any assets or categories of assets, properties, businesses or product lines of Parent or any of its affiliates or the Company or any of its Subsidiaries, even if required in order to avoid the entry of, or to effect the lifting or dissolution of, any injunction, temporary restraining order, or other Order in any suit or Proceeding, (B) undertake any behavior or conduct remedy that would be material to Parent and its Subsidiaries (assuming consummation of the Transactions), taken as a whole, or (C) to take any action or make any omission that would violate applicable Law.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (f)"
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_explanation",
        "answer": "Not applicable",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_inferred_hohw_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_materiality_basis",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "materiality_definition_text",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "refiling_commitment": [
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_required",
        "answer": true,
        "summary": "The parties are obligated to use reasonable best efforts to file all necessary documentation, including any required filings under the HSR Act, to obtain clearances for the merger.",
        "confidence": 0.9,
        "reason": "The document specifies that each party agrees to use its reasonable best efforts to file all necessary applications and filings, including those under the HSR Act.",
        "clause_text": "Each party hereto agrees to use its reasonable best efforts to file, as soon as practicable and advisable after the date of this Agreement, all applications, notices, petitions and filings required or recommended to be filed by such party with any Governmental Entity with respect to the Merger and the other Transactions, and to submit as promptly as reasonably practicable any additional information requested by any such Governmental Entity.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (b)"
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_required_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_max_refiles",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_max_refiles_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_max_refiles_specification_status",
        "answer": "Not Specified",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_clause_reference",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "termination": {
    "outside_date": [
      {
        "section": "termination",
        "field_name": "primary_date",
        "answer": "February 6, 2023",
        "summary": "The initial 'Outside Date' specified in the agreement is February 6, 2023, which is the earliest date on which either party may terminate the agreement if the merger has not yet closed.",
        "confidence": 1.0,
        "reason": "The agreement explicitly states that the Effective Time shall not have occurred on or before February 6, 2023, which is defined as the 'Original Outside Date'.",
        "clause_text": "By either the Company or Parent if the Effective Time shall not have occurred on or before February 6, 2023 (as it may be extended pursuant to this Section 7.1(d) the 'Original Outside Date');",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.1 Termination > (d)"
      }
    ],
    "extension": [
      {
        "section": "termination",
        "field_name": "extension_list",
        "answer": [
          {
            "Extension Length": "Automatically to May 5, 2023",
            "Who Grants the Extension": "Automatic",
            "Conditions to Extend": "All conditions in Article 6 other than Sections 6.1(c) (solely with respect to any Regulatory Law or any Order issued pursuant to or in respect of any Regulatory Law) or 6.1(d) have been satisfied or waived.",
            "Termination Restrictions Due to Breach": "Yes, the right to terminate is not available to any party whose material breach has principally caused the failure to close by the Outside Date."
          },
          {
            "Extension Length": "Automatically to August 7, 2023",
            "Who Grants the Extension": "Automatic",
            "Conditions to Extend": "All conditions in Article 6 other than Sections 6.1(c) (solely with respect to any Regulatory Law or any Order issued pursuant to or in respect of any Regulatory Law) or 6.1(d) have been satisfied or waived.",
            "Termination Restrictions Due to Breach": "Yes, the right to terminate is not available to any party whose material breach has principally caused the failure to close by the Outside Date."
          },
          {
            "Extension Length": "10 Business Days after the Outside Date",
            "Who Grants the Extension": "Automatic",
            "Conditions to Extend": "Conditions to Closing set forth in Article 6 are satisfied prior to the Outside Date.",
            "Termination Restrictions Due to Breach": "Yes, the right to terminate is not available to any party whose material breach has principally caused the failure to close by the Outside Date."
          },
          {
            "Extension Length": "2 Business Days after the last day of any then-pending Matching Period or Marketing Period",
            "Who Grants the Extension": "Automatic",
            "Conditions to Extend": "Any Matching Period or Marketing Period is pending.",
            "Termination Restrictions Due to Breach": "Yes, the right to terminate is not available to any party whose material breach has principally caused the failure to close by the Outside Date."
          }
        ],
        "summary": "The agreement provides for automatic extensions of the Outside Date under specific conditions, including satisfaction of certain conditions in Article 6 and pending periods like the Matching or Marketing Period.",
        "confidence": 0.95,
        "reason": "The extensions are clearly outlined with automatic triggers based on the satisfaction of conditions and pending periods.",
        "clause_text": "provided, further, that if on the Original Outside Date, all of the conditions in Article 6 other than Sections 6.1(c) (solely with respect to any Regulatory Law or any Order issued pursuant to or in respect of any Regulatory Law) or 6.1(d) have been satisfied (other than conditions that by their nature can only be satisfied on the Closing Date), or have been waived by Parent and Merger Sub and the Company, as applicable, then the Outside Date shall automatically be extended to May 5, 2023 (the 'First Extended Outside Date'); provided, further, that if on the First Extended Outside Date, all of the conditions in Article 6 other than Sections 6.1(c) (solely with respect to any Regulatory Law or any Order issued pursuant to or in respect of any Regulatory Law) or 6.1(d) have been satisfied (other than conditions that by their nature can only be satisfied on the Closing Date), or have been waived by Parent and Merger Sub and the Company, as applicable, then the Outside Date shall automatically be extended to August 7, 2023 (the 'Second Extended Outside Date') (the Original Outside Date as such date may be extended by the First Extended Outside Date and the Second Extended Outside Date, as applicable, the 'Outside Date'); provided, further, that if the conditions to Closing set forth in Article 6 are satisfied prior to the Outside Date (or in the case of conditions that by their terms are to be satisfied at the Closing, shall be capable of being satisfied on Closing Date), then the definition of the applicable Outside Date shall be deemed to be extended, and shall mean, the date that is ten (10) Business Days after the Outside Date prior to giving effect to this proviso (it being understood that this proviso shall only extend the Outside Date once); provided, further, that the definition of the applicable Outside Date shall be deemed to be extended until the date that is two (2) Business Days after the last day of any then-pending (i) Matching Period or (ii) Marketing Period.",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.1 Termination > (d)"
      }
    ],
    "termination_fee": [
      {
        "section": "termination",
        "field_name": "termination_fee",
        "answer": "$132,000,000",
        "summary": "The Company Termination Fee payable by the Target to the Parent is explicitly stated as one hundred thirty two million dollars.",
        "confidence": 1.0,
        "reason": "The document explicitly defines the Company Termination Fee as $132,000,000.",
        "clause_text": "The 'Company Termination Fee' means one hundred thirty two million dollars ($132,000,000).",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.3 Termination Fees > (a)"
      }
    ],
    "reverse_termination_fee": [
      {
        "section": "termination",
        "field_name": "reverse_termination_fee",
        "answer": 160000000,
        "summary": "The Parent Termination Fee is specified as one hundred sixty million dollars ($160,000,000).",
        "confidence": 1.0,
        "reason": "The document explicitly states the Parent Termination Fee amount.",
        "clause_text": "The 'Parent Termination Fee' means one hundred sixty million dollars ($160,000,000).",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.3 Termination Fees > (c)"
      }
    ],
    "reverse_termination_fee_exist": [
      {
        "section": "termination",
        "field_name": "reverse_termination_fee_exist",
        "answer": true,
        "summary": "The agreement includes a provision for a reverse termination fee, where the Parent is required to pay the Company a termination fee if the agreement is terminated under certain regulatory conditions.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the Parent shall pay the Parent Termination Fee to the Company under specific termination conditions related to regulatory laws.",
        "clause_text": "The parties hereto agree that (A) if this Agreement is terminated by Parent or the Company pursuant to (x) Section 7.1(c) (but solely to the extent a court of competent jurisdiction or other Governmental Entity of competent jurisdiction shall have issued an Order pursuant to a Regulatory Law (and no other Law), adopted or caused to be effective any Law (but solely to the extent it is a Regulatory Law and no other Law) or taken any other action pursuant to a Regulatory Law (and no other Law), in each case, permanently restraining, enjoining or otherwise prohibiting, prior to the Effective Time, the consummation of the Merger, and such Order or other action shall have become final and non-appealable), or (y) Section 7.1(d), (B) at the time of such termination, all of the conditions in Article 6 other than Section 6.1(c) (solely with respect to any Regulatory Law or any Order issued pursuant to or in respect of any Regulatory Law) or 6.1(d) have been satisfied or are capable of being satisfied prior to Closing (other than conditions that by their nature can only be satisfied on the Closing Date), or have been waived by Parent and Merger Sub and the Company, as applicable, and (C) at the time of such termination the Company is not in material breach of any representation, warranty, covenant or other agreement of the Company set forth in this Agreement where such breach by the Company is the primary cause of the failure of any condition to this Agreement being satisfied, then Parent shall pay to the Company prior to or concurrently with such termination, in the case of a termination by Parent, or within two (2) Business Days thereafter, in the case of a termination by the Company, the Parent Termination Fee.",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.3 Termination Fees > (c)"
      }
    ]
  },
  "ordinary_course": {
    "ordinary_course_covenant": [
      {
        "section": "ordinary_course",
        "field_name": "concise_standard_summary",
        "answer": "Parent will conduct its operations in the ordinary course of business and use commercially reasonable efforts to maintain relationships and preserve goodwill.",
        "summary": "Parent is required to conduct operations in the ordinary course of business and use commercially reasonable efforts to maintain relationships and preserve goodwill between signing and closing.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the requirement for Parent to conduct operations in the ordinary course and use commercially reasonable efforts.",
        "clause_text": "Parent will, and will cause each of its Subsidiaries (i) to conduct its operations in all material respects in the ordinary course of business, and (ii) to use commercially reasonable efforts to keep available the services of the current officers, employees and consultants of Parent and each of its Subsidiaries and to preserve the goodwill and current relationships of Parent and each of its Subsidiaries with customers, suppliers and other Persons with which Parent or any of its Subsidiaries has significant business relations.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.2 Conduct of Business by Parent Pending the Closing"
      }
    ]
  },
  "board_approval": {
    "board_approval": [
      {
        "section": "board_approval",
        "field_name": "target_board_approval",
        "answer": true,
        "summary": "The Company Board has unanimously approved, adopted, and declared advisable the Agreement and the transactions, including the Merger.",
        "confidence": 1.0,
        "reason": "The document explicitly states that the Company Board has unanimously adopted resolutions approving the Agreement and the Merger.",
        "clause_text": "The Company Board, at a meeting duly called and held in compliance with the requirements of the memorandum and articles of association of the Company, unanimously adopted resolutions (i) determining that the Transactions, including the Merger, are advisable, fair to and in the best interests of the Company and its shareholders, (ii) approving, adopting and declaring advisable this Agreement and the Transactions, including the Merger, (iii) directing that this Agreement be submitted to the shareholders of the Company for its adoption, and (iv) recommending that the Company's shareholders adopt this Agreement (the 'Company Board Recommendation') which Company Board Recommendation has not been withdrawn, rescinded or modified in any way except in accordance with Section 5.5.",
        "reference_section": "ARTICLE Article 3 Representations and Warranties of the Company > Section 3.4 Authority; Execution and Delivery; Enforceability > (b)"
      },
      {
        "section": "board_approval",
        "field_name": "target_board_unanimous",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "board_approval",
        "field_name": "acquirer_board_approval",
        "answer": true,
        "summary": "The Board of Directors of Parent has approved this Agreement and the transactions contemplated hereby, including the Merger.",
        "confidence": 1.0,
        "reason": "The document explicitly states that the Parent Board has approved the merger agreement.",
        "clause_text": "C. The Board of Directors of Parent (\"Parent Board\") has, upon the terms and subject to the conditions set forth herein, approved this Agreement and the transactions contemplated hereby, including the Merger and the issuance of shares of Parent Common Stock as consideration in the Merger (the \"Share Issuance\").",
        "reference_section": "ARTICLE Preamble"
      },
      {
        "section": "board_approval",
        "field_name": "acquirer_board_unanimous",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "party_details": {
    "acquirer": [
      {
        "section": "party_details",
        "field_name": "acquirer",
        "answer": "MAXLINEAR, INC.",
        "summary": "The acquiring entity in the merger agreement is MAXLINEAR, INC., a Delaware corporation.",
        "confidence": 0.95,
        "reason": "The preamble of the agreement explicitly names MAXLINEAR, INC. as the 'Parent,' which is typically the acquiring entity in such transactions.",
        "clause_text": "This AGREEMENT AND PLAN OF MERGER, dated as of May 5, 2022 (this \"Agreement\"), is made by and among MAXLINEAR, INC., a Delaware corporation (\"Parent\"), SHARK MERGER SUB, an exempted company with limited liability incorporated under the Law of the Cayman Islands having a registered office at Appleby Global Services (Cayman) Limited, 71 Fort Street, George Town, Grand Cayman KY1-1106, Cayman Islands (\"Merger Sub\"), and SILICON MOTION TECHNOLOGY CORPORATION, an exempted company with limited liability incorporated under the Law of the Cayman Islands and having its registered office at Codan Trust Company (Cayman) Limited, Century Yard, Cricket Square, Hutchins Drive, P. O. Box 2681 GT, George Town, Grand Cayman, British West Indies (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      },
      {
        "section": "party_details",
        "field_name": "parent_entity_details",
        "answer": "MAXLINEAR, INC.",
        "summary": "MAXLINEAR, INC. is the ultimate parent company of the acquiring entity, Shark Merger Sub, as it is the sole shareholder of Merger Sub.",
        "confidence": 0.9,
        "reason": "The Preamble and Section 1.1(a) indicate that MAXLINEAR, INC. is the parent company and sole shareholder of Merger Sub.",
        "clause_text": "This AGREEMENT AND PLAN OF MERGER, dated as of May 5, 2022 (this \"Agreement\"), is made by and among MAXLINEAR, INC., a Delaware corporation (\"Parent\"), SHARK MERGER SUB, an exempted company with limited liability incorporated under the Law of the Cayman Islands...",
        "reference_section": "ARTICLE Preamble"
      }
    ],
    "target": [
      {
        "section": "party_details",
        "field_name": "target",
        "answer": "Silicon Motion Technology Corporation",
        "summary": "The target company being acquired is Silicon Motion Technology Corporation, which is defined as 'the Company' in the agreement.",
        "confidence": 1.0,
        "reason": "The agreement explicitly defines 'the Company' as Silicon Motion Technology Corporation, which is the entity being merged into the Merger Sub.",
        "clause_text": "This AGREEMENT AND PLAN OF MERGER, dated as of May 5, 2022 (this \"Agreement\"), is made by and among MAXLINEAR, INC., a Delaware corporation (\"Parent\"), SHARK MERGER SUB, an exempted company with limited liability incorporated under the Law of the Cayman Islands having a registered office at Appleby Global Services (Cayman) Limited, 71 Fort Street, George Town, Grand Cayman KY1-1106, Cayman Islands (\"Merger Sub\"), and SILICON MOTION TECHNOLOGY CORPORATION, an exempted company with limited liability incorporated under the Law of the Cayman Islands and having its registered office at Codan Trust Company (Cayman) Limited, Century Yard, Cricket Square, Hutchins Drive, P. O. Box 2681 GT, George Town, Grand Cayman, British West Indies (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      }
    ],
    "guarantor": [
      {
        "section": "party_details",
        "field_name": "guarantor_present",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "party_details",
        "field_name": "guarantor_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "subsidiaries": [
      {
        "section": "party_details",
        "field_name": "target_subsidiaries_present",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "party_details",
        "field_name": "target_subsidiaries",
        "answer": "No target subsidiaries explicitly involved in the merger structure are mentioned.",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "party_details",
        "field_name": "acquirer_subsidiaries_present",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "party_details",
        "field_name": "acquirer_subsidiaries",
        "answer": "[{ \"name\": \"Shark Merger Sub\", \"clause_reference\": \"ARTICLE Article 1 The Merger > Section 1.1 The Merger\", \"role\": \"Wholly owned merger vehicle used to merge with the target\" }]",
        "summary": "Shark Merger Sub is explicitly referenced as a wholly owned subsidiary of the Parent, formed solely for the purpose of merging with the target company.",
        "confidence": 0.95,
        "reason": "The document explicitly states that Merger Sub was formed solely for the purposes of the Merger and is owned by the Parent.",
        "clause_text": "Merger Sub was formed solely for purposes of the Merger and, except for matters incident to formation and execution and delivery of this Agreement and the performance of the Transactions, has not prior to the date hereof engaged in any business or other activities.",
        "reference_section": "ARTICLE Article 4 Representations and Warranties of Parent and Merger Sub > Section 4.16 Ownership of Merger Sub"
      }
    ],
    "transaction": [
      {
        "section": "party_details",
        "field_name": "transaction_type",
        "answer": "Reverse Triangular Merger",
        "summary": "The transaction involves Merger Sub merging with and into the Company, with the Company continuing as the surviving entity and becoming a wholly owned subsidiary of Parent.",
        "confidence": 0.95,
        "reason": "The structure described matches a Reverse Triangular Merger, where the subsidiary (Merger Sub) merges into the target (Company), and the target survives.",
        "clause_text": "Upon the terms and subject to the conditions set forth in this Agreement, and in accordance with the CICA, at the Effective Time, Merger Sub shall be merged with and into the Company. As a result of the Merger, the separate corporate existence of Merger Sub shall cease to exist and will be struck off the Register of Companies in the Cayman Islands, and the Company shall continue as the Surviving Company under the Laws of the Cayman Islands and become a wholly owned Subsidiary of Parent.",
        "reference_section": "ARTICLE Article 1 The Merger > Section 1.1 The Merger > (a)"
      },
      {
        "section": "party_details",
        "field_name": "transaction_structure_notes",
        "answer": "Merger Sub will merge with and into the Company, with the Company continuing as the Surviving Company and becoming a wholly owned subsidiary of Parent.",
        "summary": "The transaction is structured as a merger where Merger Sub will merge into the Company, resulting in the Company continuing as the Surviving Company and becoming a wholly owned subsidiary of Parent.",
        "confidence": 0.95,
        "reason": "The structure is explicitly described in the document, detailing the merger of Merger Sub into the Company and the continuation of the Company as the Surviving Company.",
        "clause_text": "Upon the terms and subject to the conditions set forth in this Agreement, and in accordance with the CICA, at the Effective Time, Merger Sub shall be merged with and into the Company. As a result of the Merger, the separate corporate existence of Merger Sub shall cease to exist and will be struck off the Register of Companies in the Cayman Islands, and the Company shall continue as the Surviving Company under the Laws of the Cayman Islands and become a wholly owned Subsidiary of Parent.",
        "reference_section": "ARTICLE Article 1 The Merger > Section 1.1 The Merger > (a)"
      }
    ],
    "merger_sub_details": [
      {
        "section": "party_details",
        "field_name": "merger_sub_details",
        "answer": "SHARK MERGER SUB, an exempted company with limited liability incorporated under the Law of the Cayman Islands having a registered office at Appleby Global Services (Cayman) Limited, 71 Fort Street, George Town, Grand Cayman KY1-1106, Cayman Islands ('Merger Sub'), and SILICON MOTION TECHNOLOGY CORPORATION, an exempted company with limited liability incorporated under the Law of the Cayman Islands and having its registered office at Codan Trust Company (Cayman) Limited, Century Yard, Cricket Square, Hutchins Drive, P. O. Box 2681 GT, George Town, Grand Cayman, British West Indies (the 'Company').",
        "summary": "SHARK MERGER SUB is an exempted company with limited liability incorporated under the Law of the Cayman Islands and is a direct wholly owned subsidiary of Parent.",
        "confidence": 0.9,
        "reason": "The document explicitly states the full legal name, jurisdiction of incorporation, and ownership relationship of Merger Sub.",
        "clause_text": "SHARK MERGER SUB, an exempted company with limited liability incorporated under the Law of the Cayman Islands having a registered office at Appleby Global Services (Cayman) Limited, 71 Fort Street, George Town, Grand Cayman KY1-1106, Cayman Islands ('Merger Sub'), and SILICON MOTION TECHNOLOGY CORPORATION, an exempted company with limited liability incorporated under the Law of the Cayman Islands and having its registered office at Codan Trust Company (Cayman) Limited, Century Yard, Cricket Square, Hutchins Drive, P. O. Box 2681 GT, George Town, Grand Cayman, British West Indies (the 'Company').",
        "reference_section": "ARTICLE Preamble"
      }
    ]
  },
  "closing_mechanics": {
    "target_date": [
      {
        "section": "closing_mechanics",
        "field_name": "target_date",
        "answer": "2nd Business Day after satisfaction or waiver of all applicable conditions in Article 6, or the earlier of any Business Day before or during the Marketing Period specified by Parent with notice, or the 2nd Business Day after the final day of the Marketing Period.",
        "summary": "The closing date is set for the 2nd Business Day after all conditions in Article 6 are satisfied or waived, unless the Marketing Period is ongoing, in which case it occurs on the earlier of a specified Business Day or the 2nd Business Day after the Marketing Period ends.",
        "confidence": 0.9,
        "reason": "The clause specifies the closing date based on condition satisfaction and the Marketing Period.",
        "clause_text": "The closing of the Merger (the \"Closing\") will take place at 8:30 p.m. (Taiwan time) as soon as practicable, but in any event no later than the second (2nd) Business Day after satisfaction or waiver of all of the applicable conditions set forth in Article 6... if the Marketing Period has not ended... the Closing shall not occur until the date that is the earlier of (a) any Business Day before or during the Marketing Period specified by Parent on no less than two (2) Business Days' prior written notice to the Company and (b) the second (2nd) Business Day after the final day of the Marketing Period.",
        "reference_section": "ARTICLE Article 1 The Merger > Section 1.2 Closing and Effective Time of the Merger"
      }
    ],
    "marketing_period": [
      {
        "section": "closing_mechanics",
        "field_name": "has_marketing_period",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "closing_mechanics",
        "field_name": "marketing_period_details",
        "answer": "Marketing Period means the first period of fifteen (15) consecutive calendar days commencing on the later of (i) the date Parent shall have access to the Required Financial Information and (ii) the date the Company Shareholder Approval has been obtained; provided that (x) (1) none of July 5, 2022, July 3, 2023 or July 5, 2023 shall be considered a calendar day for the purposes of this definition (provided, however, that such exclusion shall not restart such period) and (2) if such fifteen (15) consecutive calendar day period has not ended on or prior to (A) August 22, 2022, then it will be deemed to not commence earlier than September 6, 2022, or (B) December 16, 2022, then it will be deemed to not commence earlier than January 2, 2023, (y) in no event shall the Marketing Period be restarted or cease to continue if additional financial statements are required to be delivered pursuant to the definition of \"Required Financial Information\" or have otherwise been provided after the Marketing Period has commenced, and (z) the Marketing Period in any event shall end on any earlier date prior to the expiration of such fifteen (15) consecutive calendar day period if the Debt Financing is consummated on such earlier date (including closing into escrow); provided, further, that if the Company shall in good faith reasonably believe that it has provided the Required Financial Information, the Company may deliver to Parent a written notice to that effect (stating in good faith when it believes it completed such delivery), in which case the Company shall be deemed to have delivered the Required Financial Information on the date specified in such notice, unless Parent in good faith reasonably believes that the Company has not completed the delivery of the Required Financial Information at the time such notice is given and, within three (3) Business Days after the date of the delivery of such notice by the Company, Parent gives written notice to the Company to that effect (stating with reasonable specificity which such Required Financial Information has not been delivered), in which case such Required Financial Information shall be deemed to have been delivered when such specific items have been delivered by the Company; provided, that such written notice from Parent to the Company will not prejudice the Company's right to assert that the Required Financial Information was, in fact, delivered; provided, further, that, notwithstanding the foregoing, the delivery of the Required Financial Information shall be satisfied at any time at which (and so long as) Parent shall have actually received the Required Financial Information, regardless of whether any such notice is delivered to the Company.",
        "summary": "The Marketing Period is a 15-day period starting after Parent receives Required Financial Information and Company Shareholder Approval, with specific exclusions and conditions.",
        "confidence": 1.0,
        "reason": "The clause explicitly defines the Marketing Period, including conditions and exclusions.",
        "clause_text": "Marketing Period means the first period of fifteen (15) consecutive calendar days commencing on the later of (i) the date Parent shall have access to the Required Financial Information and (ii) the date the Company Shareholder Approval has been obtained; provided that (x) (1) none of July 5, 2022, July 3, 2023 or July 5, 2023 shall be considered a calendar day for the purposes of this definition (provided, however, that such exclusion shall not restart such period) and (2) if such fifteen (15) consecutive calendar day period has not ended on or prior to (A) August 22, 2022, then it will be deemed to not commence earlier than September 6, 2022, or (B) December 16, 2022, then it will be deemed to not commence earlier than January 2, 2023, (y) in no event shall the Marketing Period be restarted or cease to continue if additional financial statements are required to be delivered pursuant to the definition of \"Required Financial Information\" or have otherwise been provided after the Marketing Period has commenced, and (z) the Marketing Period in any event shall end on any earlier date prior to the expiration of such fifteen (15) consecutive calendar day period if the Debt Financing is consummated on such earlier date (including closing into escrow); provided, further, that if the Company shall in good faith reasonably believe that it has provided the Required Financial Information, the Company may deliver to Parent a written notice to that effect (stating in good faith when it believes it completed such delivery), in which case the Company shall be deemed to have delivered the Required Financial Information on the date specified in such notice, unless Parent in good faith reasonably believes that the Company has not completed the delivery of the Required Financial Information at the time such notice is given and, within three (3) Business Days after the date of the delivery of such notice by the Company, Parent gives written notice to the Company to that effect (stating with reasonable specificity which such Required Financial Information has not been delivered), in which case such Required Financial Information shall be deemed to have been delivered when such specific items have been delivered by the Company; provided, that such written notice from Parent to the Company will not prejudice the Company's right to assert that the Required Financial Information was, in fact, delivered; provided, further, that, notwithstanding the foregoing, the delivery of the Required Financial Information shall be satisfied at any time at which (and so long as) Parent shall have actually received the Required Financial Information, regardless of whether any such notice is delivered to the Company.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Marketing Period"
      }
    ],
    "inside_date": [
      {
        "section": "closing_mechanics",
        "field_name": "has_inside_date",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "closing_mechanics",
        "field_name": "inside_date_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "specific_performance": {
    "specific_performance": [
      {
        "section": "specific_performance",
        "field_name": "specific_performance_available",
        "answer": true,
        "summary": "The agreement expressly states that the parties are entitled to specific performance as a remedy.",
        "confidence": 1.0,
        "reason": "The clause explicitly mentions that the parties shall be entitled to specific performance of the terms of the agreement.",
        "clause_text": "The parties hereto agree that if any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached, irreparable damage would occur, no adequate remedy at Law would exist and damages would be difficult to determine, and accordingly, (i) the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to specific performance of the terms hereof, this being in addition to any other remedy to which they are entitled at Law or in equity.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.13 Specific Performance"
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_parties",
        "answer": "Company, Parent",
        "summary": "The Company and Parent are entitled to seek specific performance under the agreement.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that both the Company and Parent can pursue specific performance.",
        "clause_text": "The Company's or Parent's pursuit of specific performance at any time will not be deemed an election of remedies or waiver of the right to pursue any other right or remedy to which such party may be entitled.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.13 Specific Performance"
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_limitations",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_financing_condition",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_financing_details",
        "answer": "Parent's obligation to consummate the transactions is not contingent upon obtaining financing.",
        "summary": "The agreement specifies that Parent's obligation to complete the transactions is not contingent on obtaining financing, as stated in the clause.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the obligation to consummate the transactions is not contingent upon financing.",
        "clause_text": "Parent understands and acknowledges that under the terms of this Agreement, Parent's obligation to consummate the transactions contemplated by this Agreement is not in any way contingent upon or otherwise subject to Parent's consummation of any financing arrangements, Parent's obtaining of any financing or the availability, grant, provision or extension of any financing to Parent.",
        "reference_section": "ARTICLE Article 4 Representations and Warranties of Parent and Merger Sub > Section 4.11 Financing"
      }
    ]
  },
  "confidentiality_and_clean_room": {
    "confidentiality": [
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_exists",
        "answer": true,
        "summary": "The agreement references a confidentiality agreement between the parties.",
        "confidence": 1.0,
        "reason": "The document explicitly mentions a 'Confidentiality Agreement' in multiple sections, confirming its existence.",
        "clause_text": "The Confidentiality Agreement, dated March 17, 2022, by and between the Company and Parent (the 'Confidentiality Agreement'), shall apply with respect to information furnished under this Section 5.4(a) by the Company, its Subsidiaries and their Representatives.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.4 Access to Information; Confidentiality"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_agreement_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_obligation_termination_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_breach_consequences",
        "answer": "The parties are entitled to an injunction or specific performance to prevent breaches of the Agreement, in addition to any other legal or equitable remedies.",
        "summary": "In the event of a confidentiality breach, the parties can seek an injunction or specific performance to prevent breaches, alongside other legal or equitable remedies.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the entitlement to injunctions or specific performance for breaches.",
        "clause_text": "The parties hereto agree that if any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached, irreparable damage would occur, no adequate remedy at Law would exist and damages would be difficult to determine, and accordingly, (i) the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to specific performance of the terms hereof, this being in addition to any other remedy to which they are entitled at Law or in equity...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.13 Specific Performance"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_post_termination_use",
        "answer": "Prohibits",
        "summary": "The agreement prohibits the use of confidential information after termination, as the confidentiality obligations in the Confidentiality Agreement survive termination.",
        "confidence": 0.9,
        "reason": "The confidentiality obligations are explicitly stated to survive termination of the agreement.",
        "clause_text": "In the event of termination of this Agreement by either the Company or Parent as provided in Section 7.1, written notice thereof shall be given to the other party or parties, specifying the provisions hereof pursuant to which such termination is made and the basis therefor described in reasonable detail and this Agreement shall forthwith become void and have no further force and effect (other than the second sentence of Section 5.4(b), Section 5.8, Section 7.2, Section 7.3, Section 7.4 and Article 8, each of which shall survive termination of this Agreement), and there shall be no liability or obligation on the part of Parent, Merger Sub or the Company or their respective Subsidiaries, officers, directors or Representatives, except with respect to the second sentence of Section 5.4(b), Section 5.8, Section 7.2, Section 7.3, Section 7.4 and Article 8;",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.2 Effect of Termination"
      }
    ],
    "clean_room": [
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_start_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_end_date",
        "answer": "Effective Time or termination of the Agreement",
        "summary": "Clean Room access terminates at the earlier of the Effective Time or the termination of the Agreement.",
        "confidence": 0.9,
        "reason": "The termination of the Agreement is linked to the Effective Time, which is a standard trigger for ending Clean Room access.",
        "clause_text": "From and after the date of this Agreement until the earlier of the Effective Time or the termination of this Agreement in accordance with Article 7...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.7 Certain Notices"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_scope_restrictions",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_breach_consequences",
        "answer": "The parties are entitled to an injunction or injunctions to prevent breaches of the Agreement and to specific performance of its terms in the event of a Clean Room protocol breach.",
        "summary": "In the event of a Clean Room protocol breach, the parties are entitled to seek an injunction or specific performance to prevent breaches of the Agreement.",
        "confidence": 0.9,
        "reason": "The clause specifies remedies for breaches of the Agreement, which would include breaches of Clean Room protocols.",
        "clause_text": "The parties hereto agree that if any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached, irreparable damage would occur, no adequate remedy at Law would exist and damages would be difficult to determine, and accordingly, (i) the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to specific performance of the terms hereof, this being in addition to any other remedy to which they are entitled at Law or in equity...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.13 Specific Performance"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_post_termination_use",
        "answer": "The agreement prohibits the use of Clean Room information after termination.",
        "summary": "The Confidentiality Agreement applies to information furnished under Section 5.4(a) and survives termination, prohibiting the use of Clean Room information post-termination.",
        "confidence": 0.9,
        "reason": "The Confidentiality Agreement's survival clause implies continued confidentiality obligations post-termination.",
        "clause_text": "The Confidentiality Agreement, dated March 17, 2022, by and between the Company and Parent (the \"Confidentiality Agreement\"), shall apply with respect to information furnished under this Section 5.4(a) by the Company, its Subsidiaries and their Representatives.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.4 Access to Information; Confidentiality > (b)"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_protection_clause_present",
        "answer": true,
        "summary": "The agreement includes a clause that requires the Company to revoke or withdraw access to any data room or non-public information in connection with a Competing Proposal.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the requirement to revoke or withdraw access to non-public information in connection with a Competing Proposal.",
        "clause_text": "The Company shall immediately cease and shall cause the Company's Subsidiaries and its and their respective directors, officers and employees, and the Company shall instruct its and its Subsidiaries' financial advisors, investment bankers, legal counsel and other Representatives to immediately cease, any and all existing discussion, activities or negotiations with any Person (other than Parent, Merger Sub or any of their respective designees or Representatives) conducted heretofore with respect to any Competing Proposal and to revoke or withdraw access of any Person (other than Parent, Merger Sub and their Representatives) to any data room (virtual or actual) hosted by the Company or any of its Subsidiaries or Representatives containing, or any other access to, any non-public information with respect to the Company or its Subsidiaries in connection with a Competing Proposal.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (b)"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_protection_clause_summary",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "complex_consideration_and_dividends": {
    "deal_consideration": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "deal_consideration_overview",
        "answer": "$23.385 per Share and 0.097 shares of Parent Common Stock per Share",
        "summary": "The total consideration offered to target shareholders includes $23.385 in cash per Share and 0.097 shares of Parent Common Stock per Share.",
        "confidence": 0.95,
        "reason": "The document explicitly states the cash and stock components of the consideration per Share.",
        "clause_text": "Each ordinary share, par value $0.01 per share, of the Company (each, a \"Share\" and collectively, the \"Shares\") issued and outstanding immediately prior to the Effective Time, other than the Excluded Shares, Dissenting Shares and Shares represented by each American Depositary Share, representing four (4) Shares (each, an \"ADS\" or, collectively, the \"ADSs\"), shall be cancelled in exchange for the right to receive (i) $23.385 per Share (the \"Per Share Cash Merger Consideration\"), and (ii) 0.097 validly issued, fully paid and nonassessable shares of Parent Common Stock.",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.1 Conversion of Securities > (a)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "deal_consideration_details",
        "answer": "$23.385 per Share and 0.097 shares of Parent Common Stock per Share; $93.54 per ADS and 0.388 shares of Parent Common Stock per ADS",
        "summary": "The merger consideration includes $23.385 in cash and 0.097 shares of Parent Common Stock per ordinary share, and $93.54 in cash and 0.388 shares of Parent Common Stock per ADS.",
        "confidence": 0.95,
        "reason": "The document explicitly states the cash and stock components of the merger consideration for both ordinary shares and ADSs.",
        "clause_text": "Each ordinary share, par value $0.01 per share, of the Company... shall be cancelled in exchange for the right to receive (i) $23.385 per Share... and (ii) 0.097 validly issued, fully paid and nonassessable shares of Parent Common Stock... Each ADS issued and outstanding immediately prior to the Effective Time... shall be cancelled in exchange for the right to receive (i) $93.54 per ADS... and (ii) 0.388 validly issued, fully paid and nonassessable shares of Parent Common Stock...",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.1 Conversion of Securities > (a) > (b)"
      }
    ],
    "proration": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "proration_exists",
        "answer": true,
        "summary": "The agreement provides for proration between different types of consideration, specifically between cash and stock.",
        "confidence": 0.9,
        "reason": "The agreement specifies that holders of Shares and ADSs will receive both cash and shares of Parent Common Stock as part of the Merger Consideration, indicating proration between stock and cash.",
        "clause_text": "Each ordinary share, par value $0.01 per share, of the Company (each, a \"Share\" and collectively, the \"Shares\") issued and outstanding immediately prior to the Effective Time, other than the Excluded Shares, Dissenting Shares and Shares represented by each American Depositary Share, representing four (4) Shares (each, an \"ADS\" or, collectively, the \"ADSs\"), shall be cancelled in exchange for the right to receive (i) $23.385 per Share (the \"Per Share Cash Merger Consideration\"), and (ii) 0.097 validly issued, fully paid and nonassessable shares of Parent Common Stock (together with the cash in lieu of fractional shares of Parent Common Stock as specified in Section 2.1(f), the \"Per Share Stock Merger Consideration\" and, together with the Per Share Cash Merger Consideration, the \"Per Share Merger Consideration\"), in each case of clauses (i) and (ii), without interest, subject to any withholding of Taxes required by applicable Law as provided in Section 2.5 and as payable in accordance with Section 2.2.",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.1 Conversion of Securities"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "proration_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "election": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "election_exists",
        "answer": true,
        "summary": "Shareholders are allowed to elect among different types of consideration, specifically cash and shares of Parent Common Stock.",
        "confidence": 0.9,
        "reason": "The document specifies that each ordinary share shall be cancelled in exchange for the right to receive both cash and shares of Parent Common Stock, indicating an election among different types of consideration.",
        "clause_text": "Each ordinary share, par value $0.01 per share, of the Company (each, a \"Share\" and collectively, the \"Shares\") issued and outstanding immediately prior to the Effective Time, other than the Excluded Shares, Dissenting Shares and Shares represented by each American Depositary Share, representing four (4) Shares (each, an \"ADS\" or, collectively, the \"ADSs\"), shall be cancelled in exchange for the right to receive (i) $23.385 per Share (the \"Per Share Cash Merger Consideration\"), and (ii) 0.097 validly issued, fully paid and nonassessable shares of Parent Common Stock.",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.1 Conversion of Securities > (a)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "election_details",
        "answer": "No election is permitted and consideration is fixed.",
        "summary": "Shareholders are not allowed to choose the form of consideration; each share is automatically cancelled in exchange for a fixed combination of cash and stock.",
        "confidence": 0.95,
        "reason": "The agreement specifies a fixed consideration of cash and stock for each share, with no mention of an election process for shareholders.",
        "clause_text": "Each ordinary share, par value $0.01 per share, of the Company (each, a \"Share\" and collectively, the \"Shares\") issued and outstanding immediately prior to the Effective Time, other than the Excluded Shares, Dissenting Shares and Shares represented by each American Depositary Share, representing four (4) Shares (each, an \"ADS\" or, collectively, the \"ADSs\"), shall be cancelled in exchange for the right to receive (i) $23.385 per Share (the \"Per Share Cash Merger Consideration\"), and (ii) 0.097 validly issued, fully paid and nonassessable shares of Parent Common Stock...",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.1 Conversion of Securities > (a)"
      }
    ],
    "cvr": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "cvr_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "cvr_details",
        "answer": "NA",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "ticking_fees": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "ticking_fees_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "ticking_fees_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "contingent_payments": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "contingent_payments_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "contingent_payments_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "company_dividends": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "company_dividends_can_pay",
        "answer": false,
        "summary": "The Company is prohibited from declaring or paying any dividends or other distributions with respect to its capital stock or other Equity Interests without the prior written consent of Parent.",
        "confidence": 0.9,
        "reason": "The document explicitly states that the Company shall not declare, set aside, make or pay any dividend or other distribution with respect to any of its capital stock or other Equity Interests without the prior written consent of Parent.",
        "clause_text": "Without limiting the foregoing, except (v) for any Permitted Action, (w) as set forth in Section 5.1 of the Company Disclosure Schedule, (x) as required by Law or Order, (y) for any action taken to comply with any COVID-19 Measures or (z) as otherwise expressly contemplated by any other provision of this Agreement, the Company shall not, and shall not permit any of its Subsidiaries to, between the date of this Agreement and the earlier of the Effective Time and the termination of this Agreement in accordance with Article 7, directly or indirectly, take any of the following actions without the prior written consent of Parent (not to be unreasonably withheld, conditioned or delayed): (e) declare, set aside, make or pay any dividend or other distribution (whether payable in cash, stock, property or a combination thereof) with respect to any of its capital stock or other Equity Interests, except for (i) dividends or other distributions paid by a wholly owned Subsidiary of the Company to the Company or another wholly owned Subsidiary of the Company and (ii) the payment of dividends declared by the Company prior to the date of this Agreement;",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.1 Conduct of Business by the Company Pending the Closing"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "company_dividends_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "parent_dividends": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "parent_dividends_can_pay",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "parent_dividends_details",
        "answer": "Parent is restricted from declaring or paying dividends with respect to its capital stock without the prior written consent of the Company, except for dividends paid by a wholly owned Subsidiary of Parent to Parent or another wholly owned Subsidiary of Parent.",
        "summary": "Parent is restricted from declaring or paying dividends on its capital stock without the Company's prior written consent, except for intra-group dividends.",
        "confidence": 0.9,
        "reason": "The clause explicitly restricts Parent from declaring dividends without consent, except for intra-group dividends.",
        "clause_text": "Without limiting the foregoing, except (w) for any Permitted Action, (x) as required by Law or Order, (y) for any action taken to comply with any COVID-19 Measures or (z) as otherwise expressly contemplated by any other provision of this Agreement, Parent shall not, and shall not permit any of its Subsidiaries to, between the date of this Agreement and the earlier of the Effective Time and the termination of this Agreement in accordance with Article 7, directly or indirectly, take any of the following actions without the prior written consent of the Company (not to be unreasonably withheld, conditioned or delayed): (b) except for dividends or other distributions paid by a wholly owned Subsidiary of Parent to Parent or another wholly owned Subsidiary of Parent, declare, set aside, make or pay any dividend or other distribution (whether payable in cash, stock, property or a combination thereof) with respect to any of its capital stock or other Equity Interests;",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.2 Conduct of Business by Parent Pending the Closing"
      }
    ],
    "collar": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "collar_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "collar_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "exchange_ratio_adjustment": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "exchange_ratio_adjustment_exists",
        "answer": true,
        "summary": "The agreement provides for an equitable adjustment to the Merger Consideration in the event of changes such as stock splits, stock dividends, or recapitalizations between the signing and closing.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that the Merger Consideration shall be equitably adjusted for events like stock splits and dividends.",
        "clause_text": "In the event that, between the date of this Agreement and the Effective Time, any change in the outstanding Shares shall occur as a result of any stock split, reverse stock split, stock dividend (including any dividend or distribution of Equity Interests convertible into or exchangeable for Shares), recapitalization, reclassification, reorganization, subdivision, combination, exchange of shares, or other similar event, the Merger Consideration shall be equitably adjusted to reflect such event and to provide to holders of Shares and ADS the same economic effect as contemplated by this Agreement prior to such event;",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.6 Adjustments"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "exchange_ratio_adjustment",
        "answer": "The exchange ratio adjustment mechanism provides for an equitable adjustment to the Merger Consideration in the event of changes in the outstanding Shares due to stock splits, dividends, recapitalizations, or similar events.",
        "summary": "The Merger Consideration will be equitably adjusted to reflect changes in outstanding Shares due to events like stock splits or dividends, ensuring the same economic effect as originally contemplated.",
        "confidence": 0.9,
        "reason": "The clause specifies adjustments to maintain the economic effect of the Merger Consideration in response to changes in the outstanding Shares.",
        "clause_text": "In the event that, between the date of this Agreement and the Effective Time, any change in the outstanding Shares shall occur as a result of any stock split, reverse stock split, stock dividend (including any dividend or distribution of Equity Interests convertible into or exchangeable for Shares), recapitalization, reclassification, reorganization, subdivision, combination, exchange of shares, or other similar event, the Merger Consideration shall be equitably adjusted to reflect such event and to provide to holders of Shares and ADS the same economic effect as contemplated by this Agreement prior to such event;",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.6 Adjustments"
      }
    ],
    "fractional_shares_handling": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "fractional_shares_handling_exists",
        "answer": true,
        "summary": "The agreement includes provisions for handling fractional shares by providing cash payments in lieu of fractional shares of Parent Common Stock.",
        "confidence": 1.0,
        "reason": "The agreement explicitly states that no fractional shares of Parent Common Stock shall be issued, and cash payments will be made instead.",
        "clause_text": "No fractional shares of Parent Common Stock shall be issued in the Merger upon the surrender for exchange of Share Certificates or with respect to Uncertificated Shares or of any ADS or otherwise, and such fractional share interests shall not entitle the owner thereof to vote or to any other rights of a stockholder of Parent. Each holder of Shares or ADS converted pursuant to the Merger that would otherwise have been entitled to receive a fraction of a share of Parent Common Stock (after aggregating all shares evidenced by the Share Certificates, Uncertificated Shares, ADSs or other acceptable evidence delivered by such holder to the Exchange Agent) shall receive, in lieu thereof and upon the terms of this Agreement, a cash payment (without interest) in an amount equal to such fractional part of a share of Parent Common Stock multiplied by the Parent Common Stock VWAP (rounded down to the nearest penny).",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.1 Conversion of Securities > (f) No Fractional Shares"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "fractional_shares_handling",
        "answer": "cash in lieu",
        "summary": "Fractional shares of Parent Common Stock will not be issued in the Merger. Instead, holders entitled to fractional shares will receive a cash payment equal to the fractional part multiplied by the Parent Common Stock VWAP.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that no fractional shares will be issued and cash will be paid instead.",
        "clause_text": "No fractional shares of Parent Common Stock shall be issued in the Merger... Each holder of Shares or ADS converted pursuant to the Merger that would otherwise have been entitled to receive a fraction of a share of Parent Common Stock... shall receive, in lieu thereof and upon the terms of this Agreement, a cash payment (without interest) in an amount equal to such fractional part of a share of Parent Common Stock multiplied by the Parent Common Stock VWAP (rounded down to the nearest penny).",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.1 Conversion of Securities > (f)"
      }
    ],
    "dividend_adjustment_mechanism": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "dividend_adjustment_mechanism_exists",
        "answer": true,
        "summary": "The merger consideration shall be equitably adjusted to reflect any stock dividend or similar event occurring between the date of the Agreement and the Effective Time.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the Merger Consideration will be adjusted for stock dividends, which includes dividends paid pre-closing.",
        "clause_text": "In the event that, between the date of this Agreement and the Effective Time, any change in the outstanding Shares shall occur as a result of any stock split, reverse stock split, stock dividend (including any dividend or distribution of Equity Interests convertible into or exchangeable for Shares), recapitalization, reclassification, reorganization, subdivision, combination, exchange of shares, or other similar event, the Merger Consideration shall be equitably adjusted to reflect such event and to provide to holders of Shares and ADS the same economic effect as contemplated by this Agreement prior to such event;",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.6 Adjustments"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "dividend_adjustment_mechanism",
        "answer": "The Merger Consideration shall be equitably adjusted to reflect any stock dividend or similar event.",
        "summary": "The merger consideration will be adjusted equitably if any stock dividend or similar event occurs between the agreement date and the effective time.",
        "confidence": 0.9,
        "reason": "The clause explicitly mentions adjustments for stock dividends and similar events.",
        "clause_text": "In the event that, between the date of this Agreement and the Effective Time, any change in the outstanding Shares shall occur as a result of any stock split, reverse stock split, stock dividend (including any dividend or distribution of Equity Interests convertible into or exchangeable for Shares), recapitalization, reclassification, reorganization, subdivision, combination, exchange of shares, or other similar event, the Merger Consideration shall be equitably adjusted to reflect such event and to provide to holders of Shares and ADS the same economic effect as contemplated by this Agreement prior to such event;",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.6 Adjustments"
      }
    ]
  },
  "law_and_jurisdiction": {
    "governing_law": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "governing_law_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "governing_law_jurisdiction",
        "answer": "Cayman Islands",
        "summary": "The agreement specifies that it shall be governed by the laws of the Cayman Islands, except for certain provisions related to material adverse effects which are governed by Delaware law.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that the agreement is governed by the laws of the Cayman Islands.",
        "clause_text": "(a) This Agreement and all claims, disputes, controversies and causes of action (whether at Law, in contract, in tort or otherwise) arising in connection with, out of or in any way relating to this Agreement (\"Relevant Matters\") shall be governed by, and construed in accordance with, the Laws of the Cayman Islands, without regard to Laws that may be applicable under conflicts of laws principles that would cause the application of the Laws of any jurisdiction other than the Cayman Islands;",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (a)"
      }
    ],
    "mae_interpretation_jurisdiction": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "mae_interpretation_jurisdiction_exists",
        "answer": true,
        "summary": "The agreement explicitly states that provisions related to the definition or occurrence of a Company Material Adverse Effect or a Parent Material Adverse Effect will be governed by the law of the state of Delaware.",
        "confidence": 1.0,
        "reason": "The agreement explicitly assigns Delaware law to govern the interpretation of the MAE clause.",
        "clause_text": "provided, however, that provisions related to the definition or occurrence of a Company Material Adverse Effect or a Parent Material Adverse Effect will be governed by, and construed in accordance with, the law of the state of Delaware.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (a)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "mae_interpretation_jurisdiction",
        "answer": "Delaware",
        "summary": "The provisions related to the definition or occurrence of a Company Material Adverse Effect or a Parent Material Adverse Effect will be governed by the law of the state of Delaware.",
        "confidence": 0.9,
        "reason": "The document explicitly states that the law of the state of Delaware governs the definition or occurrence of a Material Adverse Effect.",
        "clause_text": "provided, however, that provisions related to the definition or occurrence of a Company Material Adverse Effect or a Parent Material Adverse Effect will be governed by, and construed in accordance with, the law of the state of Delaware.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (a)"
      }
    ],
    "financing_jurisdiction": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "financing_jurisdiction_exists",
        "answer": true,
        "summary": "The agreement specifies that disputes related to the Debt Financing or the Debt Commitment Letter shall be governed by the laws of the State of New York and resolved in the Supreme Court of the State of New York, County of New York, or the United States District Court for the Southern District of New York.",
        "confidence": 0.95,
        "reason": "The agreement explicitly states the jurisdiction for financing-related disputes, indicating the State of New York as the governing law and jurisdiction.",
        "clause_text": "(c) Notwithstanding anything herein to the contrary, each of the parties agrees (i) that any action, cause of action, claim, cross-claim or third-party claim of any kind or description, whether in law or in equity, whether in contract or in tort or otherwise, against the Financing Sources relating to this Agreement or the Debt Financing or any of the transactions contemplated hereby or thereby, including but not limited to any dispute arising out of or relating in any way to the Debt Commitment Letter or the performance thereof, shall be governed by, and construed in accordance with, the laws of the State of New York, without giving effect to any choice of Law or conflict of Laws provision or rule (whether of the State of New York or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of New York (except as expressly specified in the Debt Commitment Letter, the commitment relating to any alternative financing or in any definitive document related to such financing) and (ii) that it will not bring or support any legal action or proceeding, whether in Law or in equity, whether in contract or in tort or otherwise against the Financing Sources and their respective current, former or future directors, officers, general or limited partners, stockholders, members, managers, controlling persons, Affiliates, employees or advisors in any way relating to this Agreement or any of the transactions contemplated by this Agreement, including any dispute arising out of or relating in any way to the Debt Financing or the performance thereof, in any forum other than the Supreme Court of the State of New York, County of New York or, if under applicable law jurisdiction is vested in the federal courts, the United States District Court for the Southern District of New York (and appellate courts thereof).",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (c)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "financing_jurisdiction",
        "answer": "State of New York",
        "summary": "The jurisdiction for financing-related matters is governed by the laws of the State of New York.",
        "confidence": 0.95,
        "reason": "The document explicitly states that any action or claim against the Financing Sources related to the Agreement or Debt Financing shall be governed by the laws of the State of New York.",
        "clause_text": "(c) Notwithstanding anything herein to the contrary, each of the parties agrees (i) that any action, cause of action, claim, cross-claim or third-party claim of any kind or description, whether in law or in equity, whether in contract or in tort or otherwise, against the Financing Sources relating to this Agreement or the Debt Financing or any of the transactions contemplated hereby or thereby, including but not limited to any dispute arising out of or relating in any way to the Debt Commitment Letter or the performance thereof, shall be governed by, and construed in accordance with, the laws of the State of New York...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (c)"
      }
    ],
    "exclusive_forum_clause": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "exclusive_forum_clause_exists",
        "answer": true,
        "summary": "The agreement includes an exclusive forum clause for disputes against the Financing Sources, specifying the Supreme Court of the State of New York or the United States District Court for the Southern District of New York.",
        "confidence": 0.9,
        "reason": "The agreement explicitly states that actions against the Financing Sources must be brought exclusively in specified New York courts.",
        "clause_text": "that it will not bring or support any legal action or proceeding, whether in Law or in equity, whether in contract or in tort or otherwise against the Financing Sources...in any forum other than the Supreme Court of the State of New York, County of New York or, if under applicable law jurisdiction is vested in the federal courts, the United States District Court for the Southern District of New York (and appellate courts thereof).",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (c)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "exclusive_forum_clause",
        "answer": "Supreme Court of the State of New York, County of New York",
        "summary": "The agreement specifies that any legal action against the Financing Sources related to the agreement or transactions must be brought exclusively in the Supreme Court of the State of New York, County of New York.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the exclusive forum for legal actions against the Financing Sources.",
        "clause_text": "that it will not bring or support any legal action or proceeding, whether in Law or in equity, whether in contract or in tort or otherwise against the Financing Sources and their respective current, former or future directors, officers, general or limited partners, stockholders, members, managers, controlling persons, Affiliates, employees or advisors in any way relating to this Agreement or any of the transactions contemplated by this Agreement, including any dispute arising out of or relating in any way to the Debt Financing or the performance thereof, in any forum other than the Supreme Court of the State of New York, County of New York or, if under applicable law jurisdiction is vested in the federal courts, the United States District Court for the Southern District of New York (and appellate courts thereof).",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (c)"
      }
    ],
    "financing_commitment_enforcement_venue": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "financing_commitment_enforcement_venue_exists",
        "answer": true,
        "summary": "The agreement specifies that any legal action against the Financing Sources related to the Debt Financing must be brought exclusively in the Supreme Court of the State of New York, County of New York, or the United States District Court for the Southern District of New York.",
        "confidence": 0.95,
        "reason": "The agreement explicitly states the jurisdiction for legal actions related to the Debt Financing, indicating a specified venue for enforcement.",
        "clause_text": "that it will not bring or support any legal action or proceeding, whether in Law or in equity, whether in contract or in tort or otherwise against the Financing Sources... in any forum other than the Supreme Court of the State of New York, County of New York or, if under applicable law jurisdiction is vested in the federal courts, the United States District Court for the Southern District of New York (and appellate courts thereof).",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (c)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "financing_commitment_enforcement_venue",
        "answer": "Supreme Court of the State of New York, County of New York or, if under applicable law jurisdiction is vested in the federal courts, the United States District Court for the Southern District of New York",
        "summary": "The enforcement venue for actions against the Financing Sources related to the Agreement or Debt Financing is specified as the Supreme Court of the State of New York, County of New York, or the United States District Court for the Southern District of New York.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the courts in New York as the exclusive venue for legal actions against the Financing Sources.",
        "clause_text": "that it will not bring or support any legal action or proceeding, whether in Law or in equity, whether in contract or in tort or otherwise against the Financing Sources...in any forum other than the Supreme Court of the State of New York, County of New York or, if under applicable law jurisdiction is vested in the federal courts, the United States District Court for the Southern District of New York (and appellate courts thereof).",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (c)"
      }
    ],
    "split_venue_clause": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "split_venue_clause_exists",
        "answer": true,
        "summary": "The agreement splits disputes into different jurisdictions, with general matters subject to arbitration in Singapore and financing-related disputes governed by New York law and resolved in New York courts.",
        "confidence": 0.95,
        "reason": "The agreement specifies different jurisdictions for general disputes and financing-related disputes, indicating a split venue clause.",
        "clause_text": "(b) Subject to paragraph (a) above, any Relevant Matters (except for the rights provided for in Section 238 of the CICA with respect to any Dissenting Shares, in respect of which the parties hereto hereby irrevocably submit to the nonexclusive jurisdiction of the courts of the Cayman Islands) shall be submitted to binding arbitration administered by the Singapore International Arbitration Centre (the 'SIAC')... (c) Notwithstanding anything herein to the contrary, each of the parties agrees... shall be governed by, and construed in accordance with, the laws of the State of New York... in any forum other than the Supreme Court of the State of New York, County of New York or, if under applicable law jurisdiction is vested in the federal courts, the United States District Court for the Southern District of New York...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (b), (c)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "split_venue_clause",
        "answer": "general in Cayman Islands, financing in New York",
        "summary": "The agreement specifies that general matters are governed by the laws of the Cayman Islands, while matters related to financing are governed by the laws of the State of New York.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the governing laws for general matters and financing matters, indicating a split venue usage.",
        "clause_text": "(a) This Agreement and all claims, disputes, controversies and causes of action (whether at Law, in contract, in tort or otherwise) arising in connection with, out of or in any way relating to this Agreement (\"Relevant Matters\") shall be governed by, and construed in accordance with, the Laws of the Cayman Islands... (c) Notwithstanding anything herein to the contrary, each of the parties agrees (i) that any action, cause of action, claim, cross-claim or third-party claim of any kind or description, whether in law or in equity, whether in contract or in tort or otherwise, against the Financing Sources relating to this Agreement or the Debt Financing... shall be governed by, and construed in accordance with, the laws of the State of New York...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (a), (c)"
      }
    ],
    "jury_trial_waiver": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "jury_trial_waiver_exists",
        "answer": true,
        "summary": "The agreement contains a waiver of jury trial rights, as each party irrevocably and unconditionally waives any right to a trial by jury in respect of any proceeding related to the agreement.",
        "confidence": 1.0,
        "reason": "The document explicitly states that each party waives the right to a trial by jury.",
        "clause_text": "EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY OR ANY OTHER RELEVANT MATTER (INCLUDING ANY ACTION, PROCEEDING OR COUNTERCLAIM AGAINST ANY FINANCING SOURCE).",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (d)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "jury_trial_waiver",
        "answer": "EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY OR ANY OTHER RELEVANT MATTER (INCLUDING ANY ACTION, PROCEEDING OR COUNTERCLAIM AGAINST ANY FINANCING SOURCE).",
        "summary": "The parties irrevocably waive any right to a jury trial for proceedings related to the agreement or related transactions.",
        "confidence": 1.0,
        "reason": "The clause explicitly states the waiver of the right to a jury trial.",
        "clause_text": "EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY OR ANY OTHER RELEVANT MATTER (INCLUDING ANY ACTION, PROCEEDING OR COUNTERCLAIM AGAINST ANY FINANCING SOURCE).",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (d)"
      }
    ],
    "arbitration_clause": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "arbitration_clause_exists",
        "answer": true,
        "summary": "The agreement mandates binding arbitration for dispute resolution, administered by the Singapore International Arbitration Centre.",
        "confidence": 1.0,
        "reason": "The agreement explicitly states that any Relevant Matters shall be submitted to binding arbitration administered by the Singapore International Arbitration Centre.",
        "clause_text": "Subject to paragraph (a) above, any Relevant Matters (except for the rights provided for in Section 238 of the CICA with respect to any Dissenting Shares, in respect of which the parties hereto hereby irrevocably submit to the nonexclusive jurisdiction of the courts of the Cayman Islands) shall be submitted to binding arbitration administered by the Singapore International Arbitration Centre (the \"SIAC\") and resolved in accordance with the SIAC's Arbitration Rules in force at the time of the arbitration, excluding the use of expedited procedures, and as may be amended by this Section 8.11 (the \"Rules\").",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (b)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "arbitration_clause",
        "answer": "Singapore International Arbitration Centre (SIAC)",
        "summary": "The arbitration forum for disputes related to the agreement is the Singapore International Arbitration Centre (SIAC), with arbitration conducted in Singapore.",
        "confidence": 0.95,
        "reason": "The document explicitly states that disputes shall be submitted to binding arbitration administered by the SIAC.",
        "clause_text": "Subject to paragraph (a) above, any Relevant Matters... shall be submitted to binding arbitration administered by the Singapore International Arbitration Centre (the \"SIAC\") and resolved in accordance with the SIAC's Arbitration Rules in force at the time of the arbitration...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (b)"
      }
    ],
    "ancillary_agreement_governing_law": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "ancillary_agreement_governing_law_exists",
        "answer": true,
        "summary": "The ancillary agreements specify a different governing law from the main agreement, with the Debt Financing and related actions governed by New York law.",
        "confidence": 0.9,
        "reason": "The clause specifies that actions related to the Debt Financing are governed by New York law, differing from the main agreement's Cayman Islands law.",
        "clause_text": "(c) Notwithstanding anything herein to the contrary, each of the parties agrees (i) that any action, cause of action, claim, cross-claim or third-party claim of any kind or description, whether in law or in equity, whether in contract or in tort or otherwise, against the Financing Sources relating to this Agreement or the Debt Financing or any of the transactions contemplated hereby or thereby, including but not limited to any dispute arising out of or relating in any way to the Debt Commitment Letter or the performance thereof, shall be governed by, and construed in accordance with, the laws of the State of New York, without giving effect to any choice of Law or conflict of Laws provision or rule (whether of the State of New York or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of New York (except as expressly specified in the Debt Commitment Letter, the commitment relating to any alternative financing or in any definitive document related to such financing).",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (c)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "ancillary_agreement_governing_law",
        "answer": "State of New York",
        "summary": "The governing law for any action or claim against the Financing Sources related to the Debt Financing or Debt Commitment Letter is the laws of the State of New York.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that any action or claim against the Financing Sources related to the Debt Financing shall be governed by the laws of the State of New York.",
        "clause_text": "(c) Notwithstanding anything herein to the contrary, each of the parties agrees (i) that any action, cause of action, claim, cross-claim or third-party claim of any kind or description, whether in law or in equity, whether in contract or in tort or otherwise, against the Financing Sources relating to this Agreement or the Debt Financing or any of the transactions contemplated hereby or thereby, including but not limited to any dispute arising out of or relating in any way to the Debt Commitment Letter or the performance thereof, shall be governed by, and construed in accordance with, the laws of the State of New York, without giving effect to any choice of Law or conflict of Laws provision or rule (whether of the State of New York or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of New York (except as expressly specified in the Debt Commitment Letter, the commitment relating to any alternative financing or in any definitive document related to such financing).",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (c)"
      }
    ]
  },
  "financing": {
    "committed_financing": [
      {
        "section": "financing",
        "field_name": "committed_financing_present",
        "answer": true,
        "summary": "The agreement includes a fully executed debt commitment letter, indicating committed financing.",
        "confidence": 0.95,
        "reason": "The presence of a fully executed debt commitment letter signifies committed financing.",
        "clause_text": "As of the date of this Agreement, Parent has delivered to the Company a true, complete and correct copy of a fully executed debt commitment letter, dated as of the date of this Agreement...",
        "reference_section": "ARTICLE Article 4 Representations and Warranties of Parent and Merger Sub > Section 4.11 Financing > (a)"
      },
      {
        "section": "financing",
        "field_name": "committed_financing_summary",
        "answer": "Parent has secured a Debt Financing Commitment through a fully executed debt commitment letter and fee letters, with the Commitment Parties agreeing to provide financing on a several and not joint basis, subject to terms and conditions.",
        "summary": "Parent has secured a Debt Financing Commitment through a fully executed debt commitment letter and fee letters, with the Commitment Parties agreeing to provide financing on a several and not joint basis, subject to terms and conditions.",
        "confidence": 0.9,
        "reason": "The document outlines a clear commitment from the Commitment Parties to provide debt financing, evidenced by the executed debt commitment letter and fee letters.",
        "clause_text": "As of the date of this Agreement, Parent has delivered to the Company a true, complete and correct copy of a fully executed debt commitment letter, dated as of the date of this Agreement (together with all exhibits, schedules, annexes and joinders thereto, as the same may be amended, modified, supplemented, extended or replaced from time to time in compliance with the terms of this Agreement, the 'Debt Commitment Letter') and fully executed fee letters (together with all exhibits, schedules, annexes and joinders thereto, as the same may be amended, modified, supplemented, extended or replaced from time to time in compliance with the terms of this Agreement, the 'Fee Letters') relating thereto...",
        "reference_section": "ARTICLE Article 4 Representations and Warranties of Parent and Merger Sub > Section 4.11 Financing > (a)"
      }
    ],
    "cash_on_hand": [
      {
        "section": "financing",
        "field_name": "cash_on_hand_specified_present",
        "answer": true,
        "summary": "The agreement explicitly states that cash on hand will be used to fund part of the transaction.",
        "confidence": 0.95,
        "reason": "The clause explicitly mentions that the company's cash on hand will be used along with other financial resources to fund the transaction.",
        "clause_text": "Assuming the satisfaction of the conditions set forth in Section 6.1 and Section 6.3 hereof, and subject in all respects to the terms and conditions of this Agreement, the net proceeds contemplated by the Debt Financing, together with the Company's cash on hand and cash on hand at Parent and the other financial resources available to Parent, will, in the aggregate, be sufficient for Parent to (i) pay the Per Share Cash Merger Consideration and Per ADS Cash Merger Consideration payable pursuant to this Agreement...",
        "reference_section": "ARTICLE Article 4 Representations and Warranties of Parent and Merger Sub > Section 4.12 Sufficient Funds"
      },
      {
        "section": "financing",
        "field_name": "cash_on_hand_specified",
        "answer": "The cash on hand, along with the net proceeds from the Debt Financing and other financial resources available to Parent, will be sufficient to cover all necessary payments and expenses related to the merger.",
        "summary": "The cash on hand, combined with debt financing and other resources, will cover merger-related payments and expenses.",
        "confidence": 0.9,
        "reason": "The clause specifies that cash on hand and other resources will be sufficient for all merger-related financial obligations.",
        "clause_text": "the net proceeds contemplated by the Debt Financing, together with the Company's cash on hand and cash on hand at Parent and the other financial resources available to Parent, will, in the aggregate, be sufficient for Parent to (i) pay the Per Share Cash Merger Consideration and Per ADS Cash Merger Consideration payable pursuant to this Agreement...",
        "reference_section": "ARTICLE Article 4 Representations and Warranties of Parent and Merger Sub > Section 4.12 Sufficient Funds"
      }
    ],
    "financing_efforts_summary": [
      {
        "section": "financing",
        "field_name": "financing_efforts_summary",
        "answer": "Parent shall use its reasonable best efforts to arrange, obtain and complete the Debt Financing on or before the Closing Date on the terms and conditions described in the Debt Financing Commitment.",
        "summary": "Parent is obligated to use reasonable best efforts to secure and finalize the Debt Financing by the Closing Date, adhering to the terms outlined in the Debt Financing Commitment.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the obligation of Parent to use reasonable best efforts to secure the financing.",
        "clause_text": "Parent shall use its reasonable best efforts to arrange, obtain and complete the Debt Financing on or before the Closing Date on the terms and conditions described in the Debt Financing Commitment.",
        "reference_section": "ARTICLE 5 Covenants > Section 5.16 Financing > (e)"
      }
    ],
    "substitute_financing_notice_and_efforts": [
      {
        "section": "financing",
        "field_name": "substitute_financing_notice_and_efforts",
        "answer": "The acquirer is required to notify the company if financing becomes unavailable and must use reasonable best efforts to arrange alternative financing.",
        "summary": "The acquirer must notify the company in writing if any portion of the Debt Financing becomes unavailable and use reasonable best efforts to arrange alternative debt financing.",
        "confidence": 0.9,
        "reason": "The clause explicitly requires the acquirer to notify the company if financing is unavailable and to seek alternative financing.",
        "clause_text": "if all or any portion of the Debt Financing becomes unavailable on the terms and conditions (including any applicable market 'flex' provisions) contemplated by the Debt Commitment Letter and such portion is necessary to consummate the Transactions, Parent shall promptly notify the Company in writing and Parent and Merger Sub shall use their reasonable best efforts to arrange and obtain, as promptly as practicable prior to the termination date, alternative debt financing",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.16 Financing > (h)"
      }
    ]
  },
  "proxy_statement": {
    "proxy_statement_filing_timing": [
      {
        "section": "proxy_statement",
        "field_name": "proxy_statement_filing_timing",
        "answer": "As promptly as reasonably practicable following the date of this Agreement and in any event within forty-five (45) days after the date of this Agreement",
        "summary": "The proxy statement or Form S-4 must be filed as promptly as reasonably practicable following the date of the Agreement and in any event within forty-five (45) days after the date of the Agreement.",
        "confidence": 0.95,
        "reason": "The clause explicitly states the timing requirement for filing the Form S-4, which is within forty-five (45) days after the date of the Agreement.",
        "clause_text": "(a) As promptly as reasonably practicable following the date of this Agreement and in any event within forty-five (45) days after the date of this Agreement: (i) Parent shall prepare and file with the SEC a preliminary Form S-4.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (a) > (i)"
      }
    ],
    "f4_effectiveness": [
      {
        "section": "proxy_statement",
        "field_name": "f4_effectiveness_efforts",
        "answer": "reasonable best efforts",
        "summary": "The parties must use their reasonable best efforts to have the Form S-4 declared effective under the Securities Act as promptly as reasonably practicable after filing.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that Parent shall use its reasonable best efforts to have the Form S-4 declared effective.",
        "clause_text": "Parent shall use its reasonable best efforts, and the Company shall reasonably cooperate with Parent, to have the Form S-4 declared effective under the Securities Act as promptly as reasonably practicable after such filing and to keep the Form S-4 effective as long as necessary to consummate the Merger and the Transactions, including the Share Issuance, in accordance herewith.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (a) > (i)"
      },
      {
        "section": "proxy_statement",
        "field_name": "f4_effectiveness_target_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "shareholder_meeting": [
      {
        "section": "proxy_statement",
        "field_name": "shareholder_meeting_timing",
        "answer": "The Company will hold a meeting of the Company shareholders within forty-five days following the mailing of the Proxy Statement and the Form S-4, after clearance by the SEC.",
        "summary": "The Company will hold a shareholder meeting within forty-five days following the mailing of the Proxy Statement and Form S-4, contingent upon SEC clearance.",
        "confidence": 0.9,
        "reason": "The document specifies a timeframe of forty-five days after mailing the Proxy Statement and Form S-4, which follows SEC clearance.",
        "clause_text": "The Company will, in accordance with the memorandum and articles of association of the Company, the Deposit Agreement, the CICA and all other applicable Laws, as promptly as practicable following the clearance of the Form S-4 by the SEC and in any event within forty-five (45) days following the mailing of the Proxy Statement and the Form S-4 (or such later date that Parent provides its prior written consent), hold a meeting of the Company shareholders (the \"Company Meeting\") for the purpose of seeking the Company Shareholder Approval;",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (e)"
      },
      {
        "section": "proxy_statement",
        "field_name": "shareholder_meeting_deadline",
        "answer": "within forty-five (45) days following the mailing of the Proxy Statement and the Form S-4",
        "summary": "The shareholder meeting must be held within forty-five (45) days following the mailing of the Proxy Statement and the Form S-4.",
        "confidence": 0.9,
        "reason": "The document specifies a clear deadline for holding the shareholder meeting after the mailing of the Proxy Statement and Form S-4.",
        "clause_text": "The Company will, in accordance with the memorandum and articles of association of the Company, the Deposit Agreement, the CICA and all other applicable Laws, as promptly as practicable following the clearance of the Form S-4 by the SEC and in any event within forty-five (45) days following the mailing of the Proxy Statement and the Form S-4 (or such later date that Parent provides its prior written consent), hold a meeting of the Company shareholders (the \"Company Meeting\") for the purpose of seeking the Company Shareholder Approval;",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (e)"
      },
      {
        "section": "proxy_statement",
        "field_name": "shareholder_vote_efforts",
        "answer": "The company is required to use its reasonable best efforts to obtain shareholder approval.",
        "summary": "The company shall solicit proxies in favor of the approval and adoption of the agreement and use its reasonable best efforts to obtain shareholder approval at the Company Meeting.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the company's obligation to use reasonable best efforts to obtain shareholder approval.",
        "clause_text": "Subject to the right of the Company Board to make a Company Change of Recommendation pursuant to Section 5.5, the Company shall solicit from shareholders of the Company proxies in favor of the approval and adoption of this Agreement in accordance with all applicable Laws, and shall use its reasonable best efforts to obtain the Company Shareholder Approval at the Company Meeting.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (f)"
      }
    ],
    "quorum_or_vote_failure": [
      {
        "section": "proxy_statement",
        "field_name": "quorum_or_vote_failure_handling",
        "answer": "If the meeting fails to reach quorum or shareholder approval, the Company may adjourn the meeting to allow time for additional disclosures, if there are insufficient shares represented to constitute a quorum, or if shareholder approval is unlikely to be obtained. Adjournments cannot exceed ten business days in total and no single adjournment can exceed five business days.",
        "summary": "The Company may adjourn the meeting if quorum is not met or shareholder approval is unlikely, with limits on the duration of adjournments.",
        "confidence": 0.9,
        "reason": "The clause explicitly outlines conditions under which the Company can adjourn the meeting, including failure to reach quorum or obtain shareholder approval.",
        "clause_text": "The Company may, subject to compliance with the articles of association of the Company, adjourn the Company Meeting (A) to allow time for the filing or dissemination of any supplemental or amended disclosure document that the Company Board has determined in good faith (after consultation with its outside legal counsel) is required to be filed and disseminated under applicable Law, (B) if as of the time that the Company Meeting is originally scheduled (as set forth in the Proxy Statement) or any adjournment thereof there are insufficient Shares represented (either in person or by proxy) to constitute a quorum necessary to conduct the business of the Company Meeting, (C) if the Company reasonably determines in good faith that the Company Shareholder Approval is unlikely to be obtained or (D) with the prior written consent of Parent (which shall not be unreasonably withheld, conditioned or delayed), provided, further that with respect to clauses (ii) and (iii) no such adjournments shall exceed ten (10) Business Days in the aggregate and no single adjournment shall exceed five (5) Business Days.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (e)"
      },
      {
        "section": "proxy_statement",
        "field_name": "quorum_or_vote_failure_deadline",
        "answer": "no such adjournments shall exceed ten (10) Business Days in the aggregate and no single adjournment shall exceed five (5) Business Days",
        "summary": "The document specifies that adjournments for shareholder votes shall not exceed ten business days in total, with no single adjournment exceeding five business days.",
        "confidence": 0.9,
        "reason": "The clause explicitly limits the total and individual duration of adjournments for shareholder votes.",
        "clause_text": "provided, further that with respect to clauses (ii) and (iii) no such adjournments shall exceed ten (10) Business Days in the aggregate and no single adjournment shall exceed five (5) Business Days",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (e)"
      }
    ],
    "proxy_summary_notes": [
      {
        "section": "proxy_statement",
        "field_name": "proxy_summary_notes",
        "answer": "The Company may adjourn the Company Meeting if there are insufficient Shares represented to constitute a quorum, if the Company reasonably determines that the Company Shareholder Approval is unlikely to be obtained, or with the prior written consent of Parent. Adjournments cannot exceed ten Business Days in aggregate and no single adjournment can exceed five Business Days.",
        "summary": "The Company can adjourn the shareholder meeting under specific conditions, with limitations on the duration of adjournments.",
        "confidence": 0.9,
        "reason": "The agreement specifies conditions under which the Company Meeting can be adjourned, indicating flexibility in timelines.",
        "clause_text": "The Company may, subject to compliance with the articles of association of the Company, adjourn the Company Meeting (A) to allow time for the filing or dissemination of any supplemental or amended disclosure document that the Company Board has determined in good faith (after consultation with its outside legal counsel) is required to be filed and disseminated under applicable Law, (B) if as of the time that the Company Meeting is originally scheduled (as set forth in the Proxy Statement) or any adjournment thereof there are insufficient Shares represented (either in person or by proxy) to constitute a quorum necessary to conduct the business of the Company Meeting, (C) if the Company reasonably determines in good faith that the Company Shareholder Approval is unlikely to be obtained or (D) with the prior written consent of Parent (which shall not be unreasonably withheld, conditioned or delayed), provided, further that with respect to clauses (ii) and (iii) no such adjournments shall exceed ten (10) Business Days in the aggregate and no single adjournment shall exceed five (5) Business Days.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (e)"
      }
    ]
  },
  "timeline": {
    "agreement_signing_date": [
      {
        "section": "timeline",
        "field_name": "agreement_signing_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "confidentiality_agreement_signing_date": [
      {
        "section": "timeline",
        "field_name": "confidentiality_agreement_signing_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "announcement_date": [
      {
        "section": "timeline",
        "field_name": "announcement_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "proxy_filing_deadline": [
      {
        "section": "timeline",
        "field_name": "proxy_filing_deadline",
        "answer": "As promptly as reasonably practicable following the date of this Agreement and in any event within forty-five (45) days after the date of this Agreement",
        "summary": "The preliminary proxy statement and/or registration statement on Form F-4 must be filed as promptly as reasonably practicable and within forty-five days after the signing of the agreement.",
        "confidence": 0.95,
        "reason": "The clause explicitly states the timeline for filing the Form S-4 as 'as promptly as reasonably practicable' and 'within forty-five (45) days after the date of this Agreement'.",
        "clause_text": "(a) As promptly as reasonably practicable following the date of this Agreement and in any event within forty-five (45) days after the date of this Agreement: (i) Parent shall prepare and file with the SEC a preliminary Form S-4.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (a) > (i)"
      }
    ],
    "shareholder_vote_deadline": [
      {
        "section": "timeline",
        "field_name": "shareholder_vote_deadline",
        "answer": "within forty-five (45) days following the mailing of the Proxy Statement and the Form S-4",
        "summary": "The shareholder vote must occur within forty-five (45) days following the mailing of the Proxy Statement and the Form S-4.",
        "confidence": 0.9,
        "reason": "The document specifies a timeline for holding the shareholder meeting after the mailing of the Proxy Statement and Form S-4.",
        "clause_text": "The Company will, in accordance with the memorandum and articles of association of the Company, the Deposit Agreement, the CICA and all other applicable Laws, as promptly as practicable following the clearance of the Form S-4 by the SEC and in any event within forty-five (45) days following the mailing of the Proxy Statement and the Form S-4 (or such later date that Parent provides its prior written consent), hold a meeting of the Company shareholders (the 'Company Meeting') for the purpose of seeking the Company Shareholder Approval;",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (e)"
      }
    ],
    "outside_date": [
      {
        "section": "timeline",
        "field_name": "outside_date",
        "answer": "February 6, 2023",
        "summary": "The initial Outside Date specified in the agreement is February 6, 2023, which is the earliest date on which either party may terminate the agreement if the merger has not yet closed.",
        "confidence": 1.0,
        "reason": "The agreement explicitly states February 6, 2023, as the Original Outside Date for termination if the merger has not closed.",
        "clause_text": "By either the Company or Parent if the Effective Time shall not have occurred on or before February 6, 2023 (as it may be extended pursuant to this Section 7.1(d) the 'Original Outside Date');",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.1 Termination > (d)"
      },
      {
        "section": "timeline",
        "field_name": "outside_date_extension_list",
        "answer": [
          {
            "Extension Length": "90 days",
            "Who Grants the Extension": "automatic",
            "Conditions to Extend": "All conditions in Article 6 other than Sections 6.1(c) or 6.1(d) have been satisfied or waived.",
            "Termination Restrictions Due to Breach": "Yes, the agreement restricts termination if a party's material breach caused the failure to close by the outside date."
          },
          {
            "Extension Length": "90 days",
            "Who Grants the Extension": "automatic",
            "Conditions to Extend": "All conditions in Article 6 other than Sections 6.1(c) or 6.1(d) have been satisfied or waived.",
            "Termination Restrictions Due to Breach": "Yes, the agreement restricts termination if a party's material breach caused the failure to close by the outside date."
          },
          {
            "Extension Length": "10 Business Days",
            "Who Grants the Extension": "automatic",
            "Conditions to Extend": "Conditions to Closing set forth in Article 6 are satisfied prior to the Outside Date.",
            "Termination Restrictions Due to Breach": "Yes, the agreement restricts termination if a party's material breach caused the failure to close by the outside date."
          },
          {
            "Extension Length": "2 Business Days",
            "Who Grants the Extension": "automatic",
            "Conditions to Extend": "Pending Matching Period or Marketing Period.",
            "Termination Restrictions Due to Breach": "Yes, the agreement restricts termination if a party's material breach caused the failure to close by the outside date."
          }
        ],
        "summary": "The Outside Date may be extended automatically under specific conditions, such as satisfaction of certain conditions in Article 6 or pending periods like the Matching or Marketing Period.",
        "confidence": 0.95,
        "reason": "The agreement specifies automatic extensions under certain conditions, which are standard in M&A agreements.",
        "clause_text": "if on the Original Outside Date, all of the conditions in Article 6 other than Sections 6.1(c) (solely with respect to any Regulatory Law or any Order issued pursuant to or in respect of any Regulatory Law) or 6.1(d) have been satisfied (other than conditions that by their nature can only be satisfied on the Closing Date), or have been waived by Parent and Merger Sub and the Company, as applicable, then the Outside Date shall automatically be extended to May 5, 2023 (the 'First Extended Outside Date'); provided, further, that if on the First Extended Outside Date, all of the conditions in Article 6 other than Sections 6.1(c) (solely with respect to any Regulatory Law or any Order issued pursuant to or in respect of any Regulatory Law) or 6.1(d) have been satisfied (other than conditions that by their nature can only be satisfied on the Closing Date), or have been waived by Parent and Merger Sub and the Company, as applicable, then the Outside Date shall automatically be extended to August 7, 2023 (the 'Second Extended Outside Date') (the Original Outside Date as such date may be extended by the First Extended Outside Date and the Second Extended Outside Date, as applicable, the 'Outside Date'); provided, further, that if the conditions to Closing set forth in Article 6 are satisfied prior to the Outside Date (or in the case of conditions that by their terms are to be satisfied at the Closing, shall be capable of being satisfied on Closing Date), then the definition of the applicable Outside Date shall be deemed to be extended, and shall mean, the date that is ten (10) Business Days after the Outside Date prior to giving effect to this proviso (it being understood that this proviso shall only extend the Outside Date once); provided, further, that the definition of the applicable Outside Date shall be deemed to be extended until the date that is two (2) Business Days after the last day of any then-pending (i) Matching Period or (ii) Marketing Period.",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.1 Termination > (d)"
      }
    ],
    "hsr_filing_deadline": [
      {
        "section": "timeline",
        "field_name": "hsr_filing_deadline",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "second_request_deadline": [
      {
        "section": "timeline",
        "field_name": "second_request_deadline",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "cfius_filing_deadline": [
      {
        "section": "timeline",
        "field_name": "cfius_filing_deadline",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "regulatory_approval_outside_date": [
      {
        "section": "timeline",
        "field_name": "regulatory_approval_outside_date",
        "answer": "August 7, 2023",
        "summary": "The Outside Date for the merger is initially set for February 6, 2023, but can be extended to May 5, 2023, and further to August 7, 2023, if certain regulatory conditions are not met.",
        "confidence": 0.9,
        "reason": "The document specifies extensions to the Outside Date based on regulatory conditions, extending first to May 5, 2023, and then to August 7, 2023.",
        "clause_text": "if on the First Extended Outside Date, all of the conditions in Article 6 other than Sections 6.1(c) (solely with respect to any Regulatory Law or any Order issued pursuant to or in respect of any Regulatory Law) or 6.1(d) have been satisfied (other than conditions that by their nature can only be satisfied on the Closing Date), or have been waived by Parent and Merger Sub and the Company, as applicable, then the Outside Date shall automatically be extended to August 7, 2023 (the 'Second Extended Outside Date')",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.1 Termination > (d)"
      }
    ],
    "termination_rights_trigger_dates": [
      {
        "section": "timeline",
        "field_name": "termination_rights_trigger_dates",
        "answer": "February 6, 2023",
        "summary": "The agreement may be terminated if the Effective Time has not occurred on or before February 6, 2023, with possible extensions to May 5, 2023, and August 7, 2023.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the termination right if the Effective Time does not occur by the specified dates.",
        "clause_text": "By either the Company or Parent if the Effective Time shall not have occurred on or before February 6, 2023 (as it may be extended pursuant to this Section 7.1(d) the \"Original Outside Date\"); provided, however, that the right to terminate this Agreement pursuant to this Section 7.1(d) will not be available to any party whose material breach of any representation, warranty, covenant or agreement set forth in this Agreement has principally caused, or resulted in, the Effective Time not occurring prior to the Outside Date; provided, further, that if on the Original Outside Date, all of the conditions in Article 6 other than Sections 6.1(c) (solely with respect to any Regulatory Law or any Order issued pursuant to or in respect of any Regulatory Law) or 6.1(d) have been satisfied (other than conditions that by their nature can only be satisfied on the Closing Date), or have been waived by Parent and Merger Sub and the Company, as applicable, then the Outside Date shall automatically be extended to May 5, 2023 (the \"First Extended Outside Date\"); provided, further, that if on the First Extended Outside Date, all of the conditions in Article 6 other than Sections 6.1(c) (solely with respect to any Regulatory Law or any Order issued pursuant to or in respect of any Regulatory Law) or 6.1(d) have been satisfied (other than conditions that by their nature can only be satisfied on the Closing Date), or have been waived by Parent and Merger Sub and the Company, as applicable, then the Outside Date shall automatically be extended to August 7, 2023 (the \"Second Extended Outside Date\") (the Original Outside Date as such date may be extended by the First Extended Outside Date and the Second Extended Outside Date, as applicable, the \"Outside Date\");",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.1 Termination > (d)"
      }
    ],
    "marketing_period_dates": [
      {
        "section": "timeline",
        "field_name": "marketing_period_dates",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "inside_date": [
      {
        "section": "timeline",
        "field_name": "inside_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "closing_date": [
      {
        "section": "timeline",
        "field_name": "closing_date",
        "answer": "second Business Day after satisfaction or waiver of all of the applicable conditions set forth in Article 6",
        "summary": "The closing of the Merger will occur no later than the second Business Day after the satisfaction or waiver of all applicable conditions in Article 6.",
        "confidence": 0.9,
        "reason": "The clause specifies the closing will occur on the second Business Day after conditions are met.",
        "clause_text": "The closing of the Merger (the \"Closing\") will take place at 8:30 p.m. (Taiwan time) as soon as practicable, but in any event no later than the second (2nd) Business Day after satisfaction or waiver of all of the applicable conditions set forth in Article 6 (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the fulfillment or waiver of those conditions at the Closing).",
        "reference_section": "ARTICLE Article 1 The Merger > Section 1.2 Closing and Effective Time of the Merger"
      }
    ],
    "conditions_satisfaction_end_date": [
      {
        "section": "timeline",
        "field_name": "conditions_satisfaction_end_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  }
}